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Abstract
Malignant pleural mesothelioma is a rare and lethal form of cancer affecting the
external lining of the lungs. Extrapleural pneumonectomy (EPP), which involves the
removal of the affected lung, is one of the few treatments that has been shown to have
some effectiveness in treatment of the disease [39], but this procedure carries with it
a high risk of mortality and morbidity [8]. This paper is concerned with building
models using gene expression levels to predict patient survival following EPP; these
models could potentially be used to guide patient treatment. A study by Gordon et
al built a predictor based on ratios of gene expression levels that was 88% accurate
on the set of 29 independent test samples, in terms of classifying whether or not the
patients survived shorter or longer than the median survival [15]. These results were
recreated both on the original data set used by Gordon et al and on a newer data
set which contained the same samples but was generated using newer software. The
predictors were evaluated using N-fold cross validation. In addition, other methods
of variable selection and machine learning were investigated to build different types
of predictive models. These analyses used a random training set from the newer data
set. These models were evaluated using N-fold cross validation and the best of each
of the four main types of models - decision trees, logistic regression, artificial neural
networks, and support vector machines - were tested using a small set of samples
excluded from the training set. Of these four models, the neural network with eight
hidden neurons and weight decay regularization performed the best, achieving a zero
cross validation error rate and, on the test set, 71% accuracy, an ROC area of .67
and a logrank p value of .219. The support vector machine model with linear kernel
also had zero cross validation error and, on the test set, a 71% accuracy and an ROC
area of .67 but had a higher logrank p value of .515. These both had a lower cross
validation error than the ratio-based predictors of Gordon et al, which had an N-fold
cross validation error rate of 35%; however, these results may not be comparable
because the neural network and support vector machine used a different training set
than the Gordon et al study. Regression analysis was also performed; the best neural
network model was incorrect by an average of 4.6 months in the six test samples. The
3
method of variable selection based on the signal-to-noise ratio of genes originally used
by Golub et al proved more effective when used on the randomly generated training
set than the method involving Student's t tests and fold change used by Gordon et al.
Ultimately, however, these models will need to be evaluated using a large independent
test.
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Chapter 1
Introduction
Malignant pleural mesothelioma (MPM) is an extremely rare and lethal form of can-
cer which affects the external lining of the lungs. Generally associated with exposure
to asbestos, the disease spreads rapidly; following diagnosis, median survival of pa-
tients with MPM is between nine and thirteen months [8]. Treatment of MPM has
met with very limited success, in part due to the ineffectiveness of radiotherapy and
chemotherapy. Furthermore, the rarity of the disease, coupled with the lack of a
universal staging system for MPM, has made organizing standardized clinical studies
difficult [26].
One treatment that has shown some promise in extending patient life is extrapleu-
ral pneumonectomy (EPP), which involves the removal of the entire affected lung. At
least one study has shown a significant increase in patient survival following EPP; fur-
thermore, chemotherapy and radiotherapy have been shown to be more effective when
used in combination with EPP [39]. However, the high rate of mortality and mor-
bidity associated with the procedure dictates that eligible patients be selected with
care. Ideally, patients with a long expected postoperative survival would undergo
EPP, while those with a shorter expected postoperative survival would be treated
differently to avoid the risks associated with the procedure. Although patient age
and the tumor subtype are loosely correlated with postoperative survival, there are
no reliable predictors of this survival.
The goal of this paper is to build a predictive model for postoperative patient
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survival using the gene expression levels of extracted tumors. The gene expression
levels were collected using microarray slides, which allow for the analysis of thousands
of genes in a single experiment. While the gene expression levels potentially hold a
wealth of information, analysis of expression levels for thousands of genes can be very
difficult, especially when the number of samples is small.
A research study by Gordon et al addressed the problem of predicting postopera-
tive patient survival using gene expression levels. Gordon et al built a simple predictor
based on ratios of gene expression levels; with only four genes, the ratio-based pre-
dictor was able to accurately predict all of the training samples as having a survival
greater than or less than the median survival, and was able to predict an independent
test set with 88% accuracy as well [15]. The analysis described in this paper recre-
ates the results of Gordon et al using both the original data set and a newer gene
expression level data set, which includes the same samples but was produced from
the microarray slides using newer software and so is hopefully more precise.
This paper also describes other machines learning methods for building predictive
models, as well as variable selection techniques for eliminating irrelevant genes. Since
this paper is focused on computer science and artificial intelligence rather than biology
and oncology, the biological roles of the genes used in the predictive models will not be
discussed. Models are built using four popular machine learning methods - decision
trees, logistic regression, artificial neural networks and support vector machines -
and models using different parameters are compared to one another using N-fold
cross validation. The best of each type of model is then applied to a small set
of test samples excluded from the training set; these models are compared based on
sensitivity and specificity, as well as logrank and Cox proportional hazard regression p
values. While this paper is mainly concerned with classification - that is, determining
whether a patient will survive shorter than or longer than the median survival - some
regression analysis - that is, predicting actual survival in months - is preformed as
well; regression model performance is given in terms of average sum of squares error.
The ultimate goal of this analysis is to positively affect quality of life and length of
survival among patients with MPM, since a reliable model could be used in practice to
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guide patient treatment. However, the current unavailability of a large independent
test set means some additional data collection and testing of the constructed models
must be done before any of the predictive models can be safely used in practice.
15
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Chapter 2
Background
This chapter introduces a number of important concepts used in this paper. Sec-
tion 2.1 introduces the disease being studied, malignant pleural mesothelioma, and
Section 2.2 describes the microarray technology used to collect gene expression data.
Section 2.3 describes the machine learning methods used to build the prognostic mod-
els. Section 2.4 describes the approaches used to narrow down the number of genes
to use as inputs to the predictive models. Lastly, Section 2.5 describes the methods
used to compare the various models built using different machine learning techniques
and different sets of genes.
2.1 Malignant pleural mesothelioma
MPM is a rare form of cancer affecting the pleural cells that form the external lining
of the lungs. As mentioned in Chapter 1, MPM is incurable and extremely aggressive,
spreading rapidly over affected surfaces; median survival after diagnosis is between 9
to 13 months and the five-year survival rate is only 3% [8]. MPM is most often caused
by exposure to asbestos, and the highest incidence of the disease is found among
former shipyard and construction workers, asbestos miners, and workers involved in
insulation and automobile brake manufacturing [2, 8]. While these types of workers
are at risk for a high level of exposure, even a minimal amount of asbestos exposure
in the house can lead to development of the disease [2]. Due to the lengthy latency
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period of the disease - over 30 years in most cases [2] - the average age of affected
patients is approximately 60 years [8].
Besides asbestos, other minerals such as erionite, the simian 40 virus, and exposure
to radiation have been associated with MPM [24]. There may also be a genetic factor
involved in the development of the disease [36]. Despite these other potential causes,
asbestos exposure can be found in approximately 80% of patients with MPM [2]. The
significantly increased use of asbestos following World War II [8], coupled with the
relatively recent ban on the use of asbestos and long latency period of the disease,
means that the incidence of MPM is likely to increase continually in industrialized
countries for the next few decades [36]. Furthermore, asbestos is still being mined in
many parts of Asia [36], suggesting that frequency of MPM will increase soon in that
part of the world as well.
The most common symptoms of MPM include localized chest pain, generally
caused by the cancer invading the chest wall, and shortness of breath. Liquid discharge
from the lung lining, called pleural effusion, will likely be discovered upon clinical
examination. Other symptoms include fatigue, weight loss, coughing, fever, and
profuse sweating [2]. Generally, a biopsy is needed for diagnosis, and can be performed
either by open surgery or by video-assisted thoracoscopy [8]. Due to the non-specific
nature of the symptoms and the invasive procedure needed for diagnosis, it can take
as long as 2 to 3 months from the time symptoms are presented to a physician to the
time when the disease is correctly diagnosed [39].
As the cancer progresses, it will likely invade the chest wall and eventually more
vital areas such as the heart and esophagus [2]. While metastases in distant parts
of the body are found in as many as 80% of patients [26], most patients die of local
complications. These complications include difficulty breathing, inability to eat due
to narcotics needed for pain relief as well as the cancer spreading to the esophagus,
and heart failure due to the cancer invading the heart wall [26].
Treatment for MPM is aptly described as "disappointing" [2]. The rarity of the
disease, along with the lack of uniformity in mesothelioma staging standards, has
made running studies and evaluating treatments difficult [26]. Radiotherapy is gen-
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erally difficult because of breadth of the tumors, not to mention the number of vital
organs in the proximity of the cancer. MPM has also proven very resistant to most
types of chemotherapy [36].
Surgical procedures, however, can be used to control pleural effusions and to reduce
the bulk of the cancer. When used in combination with other types of treatment,
these procedures have been shown to significantly increase patient survival [39]. The
less radical of two available treatments, pleurectomy, involves removal of the pleural
layer. This procedure is effective in controlling effusion and has a mortality rate
of less than 2%; major complications are also fairly uncommon. The more radical
procedure, EPP, involves the removal of an entire lung, and carries a much higher risk
of morbidity and mortality. The mortality rate for EPP is close to 10% [8], and major
complications occur in 24% of patients [26]. However, EPP is able to remove more
of the bulk of the cancer and makes radiotherapy more feasible due to the removed
lung. When used in combination with radiotherapy and chemotherapy, EPP has been
shown to significantly increase patient survival, with one study producing two-year
and five-year survival rates of 38% and 15%, respectively [39]. Furthermore, in the
same study, patients who had the epithelial subtype of MPM - the three subtypes of
MPM are epithelial, sarcomatoid and mixed - had an impressive median survival of
51 months [39].
While EPP has considerable promise in extending patient life and eventually pro-
viding a cure for MPM, the significant risk of morbidity and mortality associated
with the procedure warrants that patient selection be done with care. Although ep-
ithelial subtype and young age are associated with a relatively good prognosis, there
are really no known factors that are reliable predictors of patient survival; one of
the purposes of this work is to find predictors of postoperative patient survival based
on gene expression. Certainly, the ability to preoperatively predict patient survival
following EPP - using, for example, gene expression levels measured from a tumor
biopsy - would be very beneficial to the treatment of MPM; patients who are likely
to have long postoperative survival times will undergo the procedure in spite of the
risks, while those with shorter predicted survival times will be given less radical treat-
19
ments. In this way, an accurate prognostic model for MPM survival following an EPP
procedure would help to improve patient life expectancy and quality of life.
2.2 Using microarrays to analyze gene expression
While nearly all the cells in an organism contain identical DNA, the genes expressed
within the cells can vary substantially. Cells produce different proteins based on their
functions or in response to various stimuli. Although not a perfect indicator, the
amount of various molecules of mRNA within a cell is correlated with the expression
levels of corresponding genes [7].
A microarray is a glass slide with thousand of spots, with each spot containing
a strand of DNA replicated millions of times [7]. Each of these DNA strands, called
probes, tests for the presence of the corresponding complimentary mRNA molecule.
The most common type of microarrays, called spotted microarrays, compare the
relative expression levels of a test sample and a reference sample. The mRNA strands
from two the samples are labeled with opposing colors, generally red and green, and
the mRNA is allowed to hybridize with the probes. If a spot is red, presumably the
target mRNA molecule is in greater abundance - and hence the corresponding gene
has a higher expression level - in the red-labeled sample; the opposite is the case if
the spot is green. If the spot is yellow, the two samples have the same gene expression
level. Greater color intensity indicates higher gene expression level [7].
Another method used in microarrays is that of the Affymetrix company's GeneChipTM
22 to 40 oligonucleotides are used for each gene, each 25 nucleotides long. 11 to 20
of these oligonucleotides are perfectly complimentary to various sections of the target
mRNA. These oligos are the so-called perfect match strands. Each of the other 11 to
20 oligonucleotides is identical to a corresponding perfect match strand, except the
nucleotide at the central location is replaced by the complimentary nucleotide. These
oligos are the mismatch strands, which help to identify background hybridization.
Thus, the true hybridization can be quantified by subtracting the mismatch value
from the perfect match value. The early versions of Affymetrix software calculated
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the overall gene expression for a single gene as the average difference for all pairs of
oligos, using the formula
Average Difference Z Z PMiMMi (2.1)
n
where PMi and MMi are the perfect match color intensity and mismatch color in-
tensity, respectively, for the it h oligo, and n is the number of oligo pairs used to
measure the given gene [7]. This formula, however, can produce negative values for
gene expression levels if the mismatch values are large enough. Newer versions of
the software give weights to each pair of perfect match and mismatch values; pairs
with large mismatch values are given smaller weights to lessen their impact, causing
expression levels to always be nonnegative [7].
The Affymetrix company has developed a manufacturing process similar to that
used in producing silicon chips [21]; the production of oligonucleotides within the
spots is much more uniform than with spotted arrays. However, in spotted arrays,
any oligonucleotide strand can be designed and included in the array, which is not
possible with a mass-produced GeneChipTM [21].
Whichever type of microarray is used, once hybridization is complete, the microar-
ray slide is scanned, the resulting digital image is then analyzed to calculate color
intensities. The resulting data is then normalized to produce comparable measure-
ments. This process of converting the physical microarray slide into a usable data set
is not a trivial one and is increasingly becoming the job of specialists [7]. The end
result is a gene expression matrix, in which each column represents a single sample
and the rows contain expression level values for each of the target genes. Each sample
is often annotated with other patient information relevant to the problem being ad-
dressed [7]. The gene expression matrices can offer a vast amount of information, and
researchers could potentially use differentially expressed genes to aid in determining
the diagnosis or prognosis of various conditions [7]. Although microarrays have been
in use for less than a decade, they have already been used extensively in oncology
research to classify tumor types, discover new subtypes of cancer, and predict patient
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prognostic outcome [7].
Effectively analyzing a gene expression matrix can be a difficult and time-consuming
task. Researchers generally wish to identify genes that are differentially expressed
across various sets of samples, such as healthy and sick patients, or build models
which can help decide the diagnosis or prognosis for a patient.
Since microarrays are a new technology, there are few universally accepted analy-
sis methods, and many of the methods used in research reports are seemingly ad hoc.
Because they generally contain a limited number of samples and a huge number of
independent variables (the expression levels for thousands of genes), these data sets
suffer what is known as the "curse of dimensionality" [16]. Because of the dispropor-
tionately large number of variables compared to the number of samples, a model can
always be built to perfectly classify one set of samples from another; the difficulty
lies in building models which can accurately and reliably predict previously unseen
samples. Methods of machine learning used to build these models are discussed in
Section 2.3, and variable selection methods used to reduce the dimensionality of the
data are discussed in Section 2.4.
2.3 Machine learning methods
The machine learning methods used to analyze gene expression matrices are rarely
supervised learning methods; that is, training is guided by an outcome variable. In
contrast, the use of unsupervised learning methods, such as clustering, which do not
use an outcome variable, is popular. Since the data set used in this research work
contains an outcome variable, patient survival, supervised learning methods are used.
In general, the goal of supervised machine learning is to build a predictive model for
an outcome variable using a number of input variables for the samples in a partic-
ular training set [16]. The outcome variables can be either categorical or ordered.
Categorical variables are those that can take one of a number of values which have
no natural ordering, thus separating the samples into a number of classes; whether
or not a patient has a particular disease, signified with a 0 or 1, is an example of a
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categorical variable. Modeling a categorical variable is known as classification, and
can also be viewed as creating one or more decision boundaries in the input space
that separate samples of the various classes. Ordered variables, on the other hand,
can take a continuous or discrete range of values, which have a natural ordering; the
number of clays a patient survives following a treatment would be an ordered vari-
able. Modeling an ordered variable is known as regression. Some machine learning
techniques are suited for both categorical and ordered outcome variables, while others
can only handle one type or the other.
As examples, two simple types of machine learning are linear regression and K-
nearest neighbors. Linear regression attempts to fit a line to the training data, so the
predictor has the form
f(Xi) = OZ + E PkXik, (2.2)
k
where xi is the input vector for sample i, Xik is the kth input variable for sample i, a
is a constant and ok is the coefficient for the kth input variable. The best-fit line is
found by minimizing some error measure, generally residual sum of squares, defined
as
N
Residual Sum of Squares = a (y, - f(xi)) 2, (2.3)
i=l
where yi is the outcome variable for sample i and N is the number of training samples.
Residual sum of squares is generally chosen because it is differentiable as well as
simple to calculate [16]. This model is very restrictive, and cannot handle non-linear
relationships unless input transformations are explicitly added.
K-nearest neighbors uses the K nearest points in the input space to predict the
outcome of a sample. Formally, the K-nearest neighbors model is
1
f(xi) = A EZ Yj, (2.4)
j ENk (xi)
where Nk(xi) is the set, or neighborhood, of K closest training set points to the input
vector xi [16]. The distance between points is often calculated as Euclidean distance.
This type of model, especially when K = 1, is overly flexible and sensitive to the
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particular choice of training set; that is, the predictions can change significantly if
one training sample is added or removed.
In general, for a training set of finite size, there are an infinite number of models
which can predict or classify the outcomes of this set perfectly. Because of this,
nearly every type of machine learning makes some assumptions about the structure
of the underlying data and places some restrictions on the type of models which can
be generated [16]. The goal of machine learning is not to model the training set
perfectly, but to attempt to model the underlying function which generated the data;
a more complex and flexible model can perform better on the training set than a
simpler model, but may not generalize well to new samples because it may become
too sensitive to the noise in the training set [3]. When a model is too restrictive and
cannot reasonably model the data, the model is said to underfit the data. When a
model is overly complex and captures the noise in the training set rather than the
true underlying function which generated the data, the model is said to overfit the
data. Thus, the complexity of a model must be balanced carefully.
The types of machine learning described in Sections 2.3.1 through 2.3.4 are some
of the most commonly used methods. Each is generally more flexible than linear
regression but not as flexible as K-nearest neighbors.
2.3.1 Logistic regression
Similar to linear regression, logistic regression attempts to model the probability that
a sample belongs to each of the various classes. Because it models class probability,
logistic regression is used only for classification problems. Only the equations for the
two class problem will be presented here, although the logistic regression for three
or more classes is not significantly more complicated. Let 7r(xi) be the probability
that patient with input vector xi suffers some event of interest. In logistic regression,
these probabilities are modeled using the equation
ea+k kXik
7r(Xi) 1 + e k Pkik (2.5)
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where again xi is the input vector for sample i, Xik is the kth input variable for sample
i, ca is a constant and /k is the coefficient for the kth input variable. This equation
is known as the logistic probability function [10]. This equation produces values that
range from 0 to 1; clearly, if e+k 3kxik is small, the numerator is close to zero
while the denominator is close to one and, if eO+k 3kxik is large, the numerator and
denominator are approximately equal.
Using r(xi), the odds that the patient suffers the event is given by the equation
odds = - = e'+ kkXik (2.6)
1 - 7r(xi)
Taking the natural logarithm of this equation gives
log odds = log[ ( = _) + 'kXik (2.7)
Note that the logit function is defined as
logit(p) = log[ P (2.8)
where p can be any value from 0 to 1. Using this definition,
logit(r(xi)) = a + ZI3kik- (2.9)
k
Thus, the logit of the probability of the event is modeled as a linear function of the
input variables [10]. However, in this case, the coefficients are often found using
maximum likelihood rather than residual sum of squares.
The coefficients Ok have an interesting interpretation in logistic regression. Con-
sider a patient that originally has input vector xi. This patient's log odds of suffering
the event is given by
log odds = + ZE kXik- (2.10)
k
Now, if one of the patient's input variables, xij, increases by 1, giving a new input
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vector x', the patient's log odds become
log odds'= + P/kx'ik = a + PkXik + ij. (2.11)
k k
Thus, the coefficient /3 is equal to the increase in log odds associated with a 1 unit
increase in jth input variable. Furthermore, the value e3j is the odds ratio - or the
factor by which the odds increase or decrease - associated with a 1 unit increase in
the jth input variable. In logistic regression, this property is true for all values of all
input variables. Also note that logistic regression is a multiplicative model, in the
sense that, if both xij and Xik increase by 1 unit each, the resulting odds ratio is
e;ek, or the product of the two individual odds ratios [10].
It is sometimes necessary to include additional variables that capture the interac-
tion between input variables. That is, it may be the case that two variables, when
changed at the same time, have a significantly greater or lesser effect on the odds
than the product of the two effects. In this case, it would be necessary to include an
additional 3new X Xj X Xk term in the exponent of both the numerator and denominator
of the logistic probability function from Equation (2.5). Then, when both variables
increase by one, the odds increase by a factor of enewePiek, rather than simply a
factor of ei efk [10].
Logistic regression is a useful machine learning technique because the coefficients
have a natural interpretation. In logistic regression, it is common to transform a
K-class categorical input into K corresponding binary variables; however, this is only
a minor nuisance. Lastly, most statistics packages that can handle logistic regression
can also handle stepwise forward and backward variable selection, which makes finding
a good model a simple task when there are a large number of potentially informative
input variables; stepwise variable selection is discussed in Section 2.4.3.
2.3.2 Classification and regression trees
Decision trees are most commonly used for classification problems but can be applied
to regression tasks as well. Building a decision tree amounts to repeatedly splitting
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subsets of the training data, starting with the entire training set, into two distinct
subsets, until each subset meets some stopping criterion [4]. When splitting is com-
plete, each of the undivided subsets, also called terminal subsets, is assigned a class
based on the training samples contained in the subset. In general, finding the overall
optimal set of splits is intractable, so a greedy algorithm is used instead. At every
stage of the greedy algorithm, the best split is chosen based on the samples in the
current subset; then, each of the resulting subsets is examined in the same way until
the entire tree is created. Splitting is generally determined by some measure of node
impurity so that the split with the most pure resulting subsets is preferred. Thus, only
three separate features of the building algorithm need to be specified: the method to
determine each split, the criterion for stopping, and the process for assigning a class
to each terminal subset [4].
When viewed as a tree graph, the nodes of the tree represent the subsets of the
training data, with the root of the tree as the entire training set. The split at each
node determines which samples are filtered to the left subtree and which samples
are filtered to the right subtree. Each leaf node represents a terminal subset, and is
labeled with a particular class assignment. Classifying a new sample is easy and can
often be done by hand; starting at the root node, classification is done by taking the
appropriate splits based on the sample input data and following the tree to a leaf
node. The class label of that leaf node is the new sample's predicted classification.
To make calculating splits tractable, some restrictions need to be placed on the
types of splits that are allowed. First, each split can depend on only one variable. For
an ordered variable, a split must have the form xij < c, where c is a constant. For N
samples, this restriction limits the number of possible splits to N- 1. For a categorical
variable, a split must have the form xij E S, where S is a subset of the possible values
of xij. If xij can take a total of M values, there are a total of 2 M-1 possible subsets
and thus a total of 2 M -1 possible splits. However, if the outcome variable is binary,
the number of possible splits can be significantly reduced. This is done by first sorting
the M classes of the categorical variable according to the proportion of samples in
each class that have outcomes of 1; that is, if a higher proportion of samples with
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xsj = k have outcomes of 1 than samples with xij = k2, class kl will come before
class k2. If Si denotes the subset of classes with the i lowest proportions of samples
with outcomes of 1, the optimal split will always have the form xij E Si, thus giving
a total of Il - 1 possible splits [16].
These restrictions force all splits to be binary. Some algorithms allow for multi-way
splits, but multi-way splits fragment the data too quickly, leaving too few samples in
each of the resulting subsets to make good subsequent splits [4]. Furthermore, multi-
way splits bias variable selection in favor of those variables with a large number of
different values. For instance, each of the N samples could have a different value for
a particular variable, and so the tree could be split into N subsets, each containing
one sample. While the resulting subsets are completely pure, such a split is unlikely
to generalize well to new samples [31].
To determine the best split, some measure of impurity is generally used, and
the split generating the purest subsets is chosen. For a function to be a suitable
impurity measure, the function must have a maximum when all classes have equal
numbers in a subset. The function must have a minimum when a subset contains
only samples from one class. Also, the function should be symmetric, so that, in the
binary outcome case, (p1,P2) = I(P2,P1), where 1) is the impurity measure, p is
the proportional of samples in class 1 and P2 is the proportion of samples in class 2.
Functions that are concave - that is, V' < 0 - are preferred, although concavity is not
a strict requirement. Functions of this type tend to give preference to splits resulting
in one very pure subset and one very impure subset, rather than those resulting in
two equally impure subsets. The former type of split has been shown in practice to
result in better trees. In general, however, the resulting tree is fairly insensitive to the
choice of impurity measure, and so any reasonable measure can be safely chosen [4].
There are three commonly used impurity measures: misclassification rate, cross
entropy, and the Gini statistic. The misclassification rate is
Misclassification Rate = 1 - Pk,max = 1- max Pk,m, (2.12)
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cross entropy is given by
Cross Entropy = - Pk,mlogpk,m (2.13)
mEM
and the Gini statistic is calculated by
Gini Statistic = A, Pk,mPk,m' = E Pk,m(l - Pk,m), (2.14)
mom' mEM
where Pk,m is equal to the proportion of samples with class m in node k, and M is
the set of possible classes. Cross entropy and the Gini statistic are differentiable and
therefore are used more commonly than misclassification rate [16]. Misclassification
rate is also not concave and may not produce good trees.
Another feature that must be specified when building trees is the class assignment
method within leaf nodes. In most cases, the most common class of sample contained
within a leaf node determines that node's class assignment. This implicitly assumes
that the cost of misclassifying a sample of class i as class j is the same for any two
classes i and j, where i ~ j. However, this assumption may not always hold. In
medical situations, misdiagnosing a sick patient as healthy is likely to be much more
costly than misdiagnosing a healthy patient as sick, since, in the absence of proper
treatment, a sick patient could ultimately die. These varying costs can be captured in
a cost matrix, C, where Cij is the cost associated with classifying a member of class i
as class j. Note that Cii should always be equal to zero. Then, the class assignment
for a leaf node can be calculated by minimizing the total misclassification cost, using
the equation
Node Class = arg mmn CimPk,i. (2.15)
i
The class assignment within the nodes can be influenced without the use of a cost
matrix by increasing - perhaps artificially - the prevalence of the certain classes of
samples within the training set [4].
The third and final feature that needs to be specified to build a classification tree
is the stopping method. Building can continue until all leaf nodes are completely pure
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- that is, until each contains samples of only one class. However, a model using this
stopping method may be overly complex and may not generalize well; methods for
early stopping may help to reduce this overfitting. Such stopping methods include
stopping when a node size falls below a certain amount or when a node purity reaches
some percentage level. While attractive in theory, early stopping methods do not work
well in practice. It is generally better to build a full tree, stopping when nodes are
pure, and then prune the tree to the appropriate size [4].
A classification tree effectively divides the input space into a number of regions,
one for each leaf node. The decision boundaries between regions must be perpendic-
ular to the dimensions because of the restrictions placed on the possible splits.
Pruning decision trees
The most common method of pruning is cost-complexity pruning. Before describing
the pruning method, it is necessary to give several formal definitions. The total
misclassification cost for tree T is given by
R(T)= E min Ci mpk,i, (2.16)
kEleaf(T) i
where leaf(T) is the set of leaf nodes of tree T. Adding an additional measure to
penalize the size of tree T gives the cost-complexity measure
R,(T) = R(T) + alleaf(T) , (2.17)
where ca is a constant. A larger value of a gives a larger penalty for tree size. For
a given value of a, let T(a) be the subtree of T that minimizes the cost-complexity
function R,(T). If two distinct subtrees have the same value of T(oa), the smaller of
the two subtrees is selected so that T(a) is always unique. Note that, when a = 0, the
"optimal" subtree is T, and as a increases, the size of the optimal subtree decreases
until only the root of the tree remains [4].
For one final definition, let Tk be the subtree of T rooted at node k, and let k}
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be the subtree of consisting only of node k. Then,
R,(Tk) = R(Tk) + clleaf(Tk)l (2.18)
and
R, ({k}) = R(k) + oa. (2.19)
For some critical value of c, these two equations will be equal, at which point the
single node k is preferred to the subtree Tk. This value of c is given by the formula
R(k) - R(Tk)
acritical I lea f(Tk) (2.20)
This calculations forms the basis of cost-complexity pruning [4].
The cost-complexity pruning algorithm starts with the full tree T and finds the
internal node - an internal node is any non-leaf node - with the smallest value of
Ocritical. The tree is pruned at this node, and the resulting tree, T1, is stored. Then,
starting with T1, the remaining internal node with the lowest value of Oxcritical is found,
the tree T1 is pruned at this node, and the resulting tree, T2, is stored. This process
continues until only the root node of the original tree remains. The process is known
as weakest link pruning. The result is a list of trees in decreasing order of size - T,
T., T2, ... , {t}, where {t} is the tree containing only the root node of T. A hold-out
set can then be used to evaluate the performance of each of these trees, and the one
with the best performance on the hold-out set is selected [4].
Regression trees
Regression trees work in much the same way as classification trees. The goal is to
divide the input space into a number of regions, and assign each region an outcome
value. With regression trees, however, the outcome assigned to each region is not a
class assignment, but rather a constant value to approximate the ordered outcome
value. Minimizing an error measure, typically sum of squares, is used to determine
the outcome value associated with each region. That is, the constant outcome value
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k assigned to a region R is
k = argmin E (yi- k)2 = averagez Ryi, (2.21)
iER
since the arithmetic mean minimizes the sum of squares error, giving a total error of
Error = , (y, - k)2. (2.22)
xiER
Thus, when making splits, the goal is to minimize the total error in the two resulting
regions. For a split that separates the samples into two regions R1 and R 2, the total
error is given by
Error = [ 3 (yi - kl)2 + E (Yi - k2)2], (2.23)
xiER 1 xi ER 2
where k and k2 are the means of the outcomes of training samples in regions R1
and R2, respectively. The best split can then be found by searching all variables
and all possible split points to find the variable and split point which minimizes
Equation (2.23) [16].
As in classification trees, a method is needed to determine when to stop build-
ing a regression tree. It is possible to stop early, perhaps when the decrease in sum
of squares error from a split is less than some threshold; once again, however, it
is generally better to build a full tree and prune back using cost-complexity prun-
ing. Cost-complexity pruning for regression trees is equivalent to method used for
classification trees except the cost-complexity measure is now
E,(T) = ( E E (yi - kk)2) + cleaf(T)L (2.24)
kEleaf(T) xi ERk
A hold-out set is again needed to determine which of the resulting list of trees performs
the best on predicting new sample values [16].
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Advantages and disadvantages of decision trees
Classification and regression trees offer a number of advantages over other types of
learning methods. First of all, the algorithm to build trees is very fast computation-
ally, and can handle a large number of input variables, since there are a limited num-
ber of splits for each variable. Second, there are very few parameters to specify when
building a decision tree [4], none of which require a great deal of fine-tuning. Third,
decision trees make no assumptions about the distribution of variables or about the
independence of variables [31]. No additional parameters, like the interaction terms
needed in logistic regression, are needed to handle variables in decision trees. Lastly,
and perhaps most importantly, some decision trees are easy for a human to interpret;
in many cases, a surprisingly simple tree may be generated to handle a seemingly
complicated classification or regression problem [31].
There are a number of disadvantages associated with decision trees as well. First
and foremost, because of the restriction places on possible splits, all decision bound-
aries must be perpendicular to one of the dimensions, making all decision regions
hyperrectangular [31]. This means that decision trees cannot directly handle some
simple linear relationships, such as decision boundary of the form il - i2 = 0, and
some more complicated, non-linear relationships. A tree will likely have to make a
number of inaccurate splits to handle such a decision boundary, and these splits are
likely to generalize poorly. Some tree-building algorithms explore linear combinations
of variables when making splits, but this can significantly increase computation time
and, more importantly, reduce the interpretability of the resulting tree. Second, trees
are instable; a small change in the training set can lead to a completely different tree,
since changes in higher splits propagate to lower splits in a tree. Third, while trees
are easy to interpret, they may not always give a complete description of underlying
structure of the problem due to variable masking. That is, while one variable may
have been selected for a particular split, another variable may be able to generate a
split that is almost as good [4]. The tree gives the false sense that the first variable is
very relevant to the problem while the second variable is useless, when in reality the
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two may be almost equally important.
Decision trees cannot easily handle problems that, by their nature, have a large
number of decision regions. For example, classifying a disease that is present if and
only if p out of a potential q factors are present would require a very large number of
decision regions, and a classification tree would be unlikely to find the true structure
of the problem [31]. Furthermore, while decision trees are computationally suited to
handle a large number of input variables, having a large number of input variables
increases the chance of finding an irrelevant input that can split a given subset well,
and so decision trees suffer, to some extent, the curse of dimensionality that plagues
other machine learning methods [31]. Lastly, the greedy algorithm chooses the optimal
split based on the current subset of training samples; there is no reason to believe
that each split is optimal for the overall tree structure [4].
Despite their limitations, trees have proven to be fairly effective in practice and,
because of their interpretability, often give some insight into the underlying nature
of the problems being solved.
2.3.3 Artificial neural networks
Artificial neural networks have a strong relationship to biologic neural structures, and
indeed their original motivation stems from the mathematical formulation of a neuron
by McCulloch and Pitts in the 1940's [32]. A biological neuron is a cell containing
a long offshoot called an axon, which branches off at the end to form synapses with
other neurons. Chemicals released at the synapse increase or decrease the potential
of the connected neurons. If this potential within a neuron exceeds some threshold,
a pulse called an action potential travels down the axon and causes the release of
chemicals at the synapses, which in turn excite or inhibit other neurons [17].
An artificial neural network consists of a number of interconnected artificial neu-
rons. Each artificial neuron, except those which are connected to the inputs of the
network, receive inputs from a number of other neurons. These inputs are weighted
and summed, and the output of the neuron is calculated by passing this weighted
sum through an activation function. A constant, called a bias, is often added to the
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weighted sum. Mathematically, the output of a neuron j is given by
yj = fj(aj + E Wzijyi), (2.25)i-j
where fj is the activation function, aj is the bias, wij is the weight for the connection
between neuron i and neuron j, and y, is the output of the it h neuron [32]. Note that
the neuron output yj should not be confused with the outcome variable for a sample;
the distinction between the two will be clear by context.
In most cases, networks are separated into layers, such that each neuron in a
layer receives inputs only from the neurons in the previous layer. The first layer
is connected to the input values and the final layer generates the network output
values. Layers between the input and output layers are referred to as hidden layers.
Networks containing connections from nodes in later layers to nodes in the earlier
layers, thus forming loops, are called recurrent networks. Feed-forward networks, on
the other hand, do not contain loops. A feed-forward network with one hidden layer
using the appropriate activation functions can approximate any continuous function
with arbitrary accuracy if enough hidden neurons are used, and a network with two
hidden layers can approximate any function [3]. Only feed-forward networks will be
discussed here.
There are many common activation functions used in neural networks. For hidden
layer neurons, the sigmoid function, defined as
f(x) = 1 - (2.26)
is the most common function. This function ranges from 0 to 1, with the parameter
a determining how fast it goes from one extreme to the other. Another common
activation function for hidden neurons is the hyperbolic tangent function, given by
ex _- e-xf(x) =ex + e (2.27)
The hyperbolic tangent function is similar to the sigmoid function, but, because of
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the shape of this function, networks using hyperbolic tangent activation functions
tend to train faster than those using sigmoid activation functions. Lastly, the linear
function
f(x) = (2.28)
can be used in hidden nodes; however, training a network that contains only linear
activation functions is equivalent to performing linear regression. For output neurons,
the sigmoid activation function is frequently used for classification problems, since its
output ranges for 0 to 1. For a K-class classification problem, one output neuron is
needed for each of the K classes. For regression problems, output neurons often use
linear activation, since the output values are not limited to the range [0, 1].
Note that input neurons are generally just used to pass input values to neurons
next layer and so can be seen as using linear activation with no bias.
Training artificial neural networks
The most common algorithm used to train neural networks is back-propagation. Back-
propagation effectively calculates the error gradient with respect to each weight, and
updates each some small amount in the negative direction of the gradient. To see this
mathematically, let xj denote the weighted, summed input to neuron j, given by
Xj = ~aj + E WijYi, (2.29)i-j
and let yj denote the output of the neuron, as given in Equation (2.25). Again, xj
should not be confused with the input vector for sample j; the meaning will be clear
from context. Then, the error with respect to weight wij is
AE OE Ax; aE tE Oyj , 3E
=wE - x1 - i = aYi Y i fj'(xj) Yi j, (2.30)dWij aXj Wij Xj 9yj aXj adj
where 6j is defined as
i = fj(Zj)OE (2.31)O yj
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The error measure is often chosen as sum of squares. For output neurons, 6 can
be calculated directly from the derivatives of the error measure and the activation
function. For neurons in earlier layers, can be calculated using the 6 values for
neurons in subsequent layers, using the formula
OE _ fwEj = f(xj) = f(xj) E Wjk = fj(xj) Y Wjk6k. (2.32)f; 9yj =J\jk &Xk j-*k
Finally, once the values have been calculated, the weight changes are given by
Awij = -7l6jYi, (2.33)
where ir is known as the learning rate [32].
Using Equation (2.32), the 6 values for each neuron depend only on values of
neurons in subsequent layers. Thus, back-propagation is a two-pass algorithm; the
first pass starts with the network inputs and propagates the neuron outputs forward
until the network output is calculated, and the second pass starts at the output
neurons and propagates the values backward until all are calculated. When the
weights are updated after each training sample, the training process is said to be
online or incremental. Each training sample can be selected randomly, making the
process stochastic. The weights may be updated only after a number, potentially all,
of the samples, in which case the training is said to be batch, and the formula used
to update the weights is
Awij = -/71 EA yyl, (2.34)
where 65 and y are the 6j and output value, respectively, for neuron j and training
sample [17]. Online training, whether stochastic or not, is generally preferred to
batch training because gradient movements tend to cancel in batch training, making
online converge faster, and batch training is more likely to get stuck in local minima,
instead of finding the global minimum of the training error [32].
A momentum term is often added to Equation (2.34), making the formula to
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update the weights
Awij,new = P-7i z 5Y + (a* AWij,old, (2.35)
where a, the momentum coefficient, must be greater than or equal to 0 and less than
1, and AWij,old is the weight change from the previous iteration of the algorithm.
The momentum term helps to accelerate large drops in the error function, while
minimizing oscillations [17].
There are a number of methods to determine when to stop network training.
Training can be stopped after a set number of epochs - iterations through the complete
training set -- or after a set amount of computation time. Training can also be stopped
when the error, either for the training set or hold-out set, falls below some constant
value or decreases by less than some constant amount after a given epoch. Lastly,
training can stop once the error on the hold-out set begins to increase [3].
Overfitting is often a problem in neural networks, especially when the training set
is small or the network size is overly large. Some form of early stopping may be used
to prevent overfitting, but, as in classification trees, determining the appropriate time
to stop is difficult, and early stopping generally performs poorly in practice. A more
effective way to combat overfitting is known as regularization, in which a penalty term
is added to the error function to penalize large weights. The most common form of
regularization is called weight decay, which adds a penalty term to the error measure,
effectively making the new error measure
1
=E + v( 2' w..), (2.36)
where v is a constant which controls how much of an effect the regularization penalty
has. Adding the penalty term to the error measure effectively adds an additional
term -vwij to the weight update equation given in Equation (2.35). Using weight
decay regularization, unless they are reinforced by training, the network weights decay
exponentially to 0. This helps to avoid overfitting [3].
Pruning can also be used to help prevent overfitting. In neural network pruning,
the network is completely trained, then one or more weights are removed and the
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network is completely trained again. This process can be repeated one or more times.
A simple type of pruning simply removes the weights with the smallest magnitudes.
While this is easy to calculate, it performs poorly in practice. A more sensible ap-
proach attempts to calculate how much the total error would increase if each weight
was removed and prunes the weights with the smallest such values. While this type of
pruning performs significantly better in practice, it requires significantly more com-
putation. Two implementations of this type of approach are known as optimal brain
damage and optimal brain surgery [3].
Choosing the appropriate values for the parameters used in building neural net-
works is generally not an easy task. There are a large number of parameters that need
to be set, including the network size, learning rate, momentum, regularization con-
stant v, the stopping method and the method to generate the initial weights. Small
changes in one or more of these factors can significantly change the learning process.
For example, too small of a learning rate can cause training to proceed too slowly,
whereas too large of a learning rate can cause training to overshoot minima in the
error function, thus causing it not to converge [17]. Likewise, choosing a network size
that is too small will not allow the network to approximate the appropriate function,
and choosing too large a size will make the network more likely to overfit the data;
generally, however, it is better to choose too large of a size and avoid overfitting by
using regularization or pruning [3]. While there may be guidelines to determine ap-
propriate values for each of the network parameters, a sizable amount of trial and
error is needed to find the optimal values.
Advantages and disadvantages of neural networks
Neural networks have received a lot of attention over the past few decades for their
ability to approximate any function with arbitrary accuracy; this is by far their biggest
strength as a machine learning technique. Training, while often time-consuming,
proceeds automatically. Furthermore, neural networks can also easily handle both
classification problems and regression problems.
However, there are a number of drawbacks to using neural networks. First of all,
39
neural networks are not easily interpretable. By looking at a network graph or, even
worse, a list of network weights, it is nearly impossible for a human to determine the
relationships of the various input variables to the outcome variable. Secondly, there
are a large number of parameters that need to be set; choosing appropriate parameter
values that can generate a network which will generalize well to new samples can be
a difficult process. Third, training, especially back-propagation, can proceed very
slowly, especially when there are a large number of input variables or a large number
of training samples. Lastly, training has a tendency to overfit the training data or to
get stuck in local minima, preventing the network from finding the global minimum
of the training error.
Despite their drawbacks, artificial neural networks are generally a very powerful
and flexible machine learning technique, and are very common in practice.
2.3.4 Support vector machines
A support vector machine (SVM) attempts to classify a number of samples by nonlin-
early mapping the input vectors into a higher-dimensional space, and then finding the
optimal separating hyperplane between classes in the new space, which is also called
the feature space. The linear separator in the feature space generally corresponds to
a nonlinear separator in the original input space [33]. The mapping from the input
space to the feature space can be seen as a function h(xi), defined as
h(xi) = (hi(xi), h2 (xi), ... , hm(xi)), (2.37)
where hm(xi) is known as the mth transformation of xi [16]. SVMs are generally
applied to classification problems; only two-class classification problems will be dis-
cussed here, although SVMs can be extended to handle both multiple classes and
regression problems.
The general theory behind optimal separating will be discussed before highlighting
their use in combination with nonlinear mappings. Note that, for the discussion of
separating hyperplanes and SVMs, the outcome variable yi will be assumed to be
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equal to -1 or 1, rather than 0 or 1, depending on the class; this helps to simplify
many of the formulas.
Optimal separating hyperplanes
A separating hyperplane, generally defined as f(xi) = b + xjw = 0, divides the input
space into two region, with each region containing samples belonging to only one
class. With this definition, the vector w* = w is normal to the hyperplane, and
the signed distance from a point xi to the hyperplane is given by ii-11f(xi) [16]. For
a given set of linearly separable samples, there are an infinite number of separating
hyperplanes.
The optimal separating hyperplane is defined as the separating hyperplane with
the largest distance to the closest point in each of the two classes; equivalently, the
optimal separating hyperplane has the widest separating margin between the two
classes. The optimal separating hyperplane is an attractive solution because it is
unique and it is the most likely to generalize well to new samples. The optimal
separating hyperplane can be found by solving the optimization problem
maximize C w.r.t. b, w (2.38)
(2.38)
subject to 1 x1yi(b + xTw) > C, for each training sample i,
where b is a constant, w is a vector of constants, xi is the input vector for training
sample i and yi is the outcome variable for training sample i. Since yi = ±1t, the
constraints require that all points are on the correct side of the separating hyperplane,
and that each is at least a distance of C away from the hyperplane. The hyperplane
defined by f(xi) = 0 is unchanged for any constant multiple of b and vector w, and
so, setting IIwII = , the optimization problem given in (2.38) simplifies to
minimize mrlw.2 w. .t. b, w
subject to y(b + w) > 1, for all (2.39)
subject to yi(b + xTw) > 1, for all i.
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The equivalent Lagrange primal function is
Lp= Iw 2 - oi[yi(b + xTw)- 1], (2.40)
2
where ai is the ith Lagrange multiplier. Equation (2.40) is to be minimized with
respect to b and w. Setting the derivatives with respect to b and w equal to zero gives
W = Ei otiYiXi, and (2.41)
0 = i oiYi, (2.42)
which can be substituted into Equation (2.40) to the give Wolfe dual problem, which
is
maximize LD = i ai - Ei j aiajyiyxTx (2.43)2 (2.43)
subject to ai > 0 and Ti aiyi = 0.
This can be solved by many common software packages [16].
A property of the solution to the optimization problem (2.43) is that it must
satisfy the Karush-Kuhn- Tucker complementarity conditions, one of which is given
by
oai[yi(b +x'w) - 1] = 0, for all i. (2.44)
This implies that, for every point xi with a nonzero value of ai, yi(b + xiTw) = 1, in
which case xi lies on the margin and is called a support vector. All other points have
ci = 0 and yi(b + xiTw) > 0, so they do not lie on the margin; the constraints for
these points do not factor into the optimization problem, nor are these points used
in the solution for b or w [33].
Once the optimal values of aci are found, w can be calculated using equation (2.41)
and b can be found by applying equation (2.44) to any support vector. The resulting
classifier is given by
G(xi) = sign(b + XTW); (2.45)
that is, all points on one side of the hyperplane are classified as one class, and all on
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the other side of the hyperplane are classified as the other [33].
The method for finding the optimal separating hyperplane given in previous para-
graphs can only be applied to linearly separable problems. It is often useful to be
able to find the optimal separating hyperplane when the classes are not linearly sep-
arable by allowing some amount overlap between the two classes. This is done by
introducing slack variables i into the optimization problem (2.38), thus giving a new
optimization problem
maximize C w.r.t. b, w
subject to 1-yi (b + xTw) > C(1 - ), for all i, (2.46)
(i > 0 for all i and Ei i < K,
where K is a constant. Here, i is proportional to the amount by which the ith sample
is on the incorrect side of the margin, and so limiting the sum of all the slack variables
to be less than a constant limits the total amount by which all samples are allowed
to be on the incorrect side of the margin [16]. Again setting Ilwl = 1/C, gives the
optimization problem
minimize 1wl 2 + -y Zi i w.r.t. b, w
subject to yi (b + x'w) > 1 - , for all i (2.47)
and i > 0, for all i,
where y has replaced K from the problem given by (2.46); the effects of the two
parameters are inversely proportional [16]. The method used to transform and solve
the optimization problem given in (2.47) is equivalent to the method used to solve
the problem given in (2.39); the description is omitted here for brevity.
For the optimal separating hyperplane problem where some overlap is allowed
between the classes, the y parameter can be adjusted to give various separating
hyperplanes. If y is large, the -y i (i term in problem (2.47) has a large effect on
the minimization, and so very little overlap is allowed between the points and the
margin; when y is equal to infinity, all points must be on or outside the margin, as in
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the original optimal separating hyperplane. Likewise, if -y is small, the -y i (i term
in problem (2.47) has a small effect on the minimization, and so considerable overlap
is allowed [16].
SVMs using feature space mappings
SVMs add more flexibility to the linear optimal separating hyperplane method by
calculating the separating hyperplane in a higher-dimensional feature space. The
separating hyperplane in the feature space often corresponds to a nonlinear separating
boundary in the original input space.
Given a mapping h(x), as defined in Equation (2.37), the Wolfe dual function that
needs to be maximized to find the optimal separating hyperplane is
1LD = E ai - I E E oaiajyiyjh(xi)Th(xj), (2.48)
i 2 j
and so the optimization problem depends only on the dot product of two transformed
vectors, rather than the actual transformed vectors themselves. Because of this, the
mapping h(x) itself is never needed, rather only the Kernel function
K(xi, xj) = h(xi)Th(xj) (2.49)
is needed [16].
There are many common kernels used in SVMs. The polynomial kernel of d
dimensions is given by
K(xi, xj) = (XXj)d. (2.50)
The polynomial kernel
K(xi, xj) = (1 + xiTj)d (2.51)
includes all dimensions up to and including d. Two other common kernel functions
are the sigmoid kernel
K(xi, xj) = ((xTZj) + O), (2.52)
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where N and E are constants, and the radial basis kernel
-l:._-¢ .112
K(xi, xj) = e 2a2 , (2.53)
where a is a constant. The appropriate choice of kernel depends on the specific
problem being classified and often requires trial and error to find the one which
performs the best [33].
Given a Kernel function K(xi, xj), the Wolfe dual becomes
1
LD = i - 2 E E aiajyiyjK(xi, xj), (2.54)i j
which can be solved to give the optimal separating hyperplane in the new feature
space. The resulting optimal separating hyperplane in the feature space is given by
f(xi) = h(xi)Tw + b = a jyjK(xi, xj) + b. (2.55)
As always, the classifier based on this separating hyperplane is given by the sign of
f(xi).
In a higher-dimensional space, there will generally always be a hyperplane which
can completely separate the training set without any overlap between the classes, so
the y parameter is used as a type of regularization to avoid overfitting. If y is very
large, the separating hyperplane will not contain much overlap between the classes,
and so the resulting separator in the original space will likely be highly curved and
may overfit the training samples. If y is small, the separating hyperplane will be less
sensitive to the particular choice of training set, and so the boundary will be much
smoother in the original input space [16].
Advantages and disadvantages of SVMs
SVMs have become popular recently, in part, because they take advantage of the
theoretically attractive method of optimal separating hyperplanes. Also, with the
appropriate choice of Kernel function, an SVM can classify any function and can
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avoid overfitting with use of the y parameter.
When using an SVM, the choice of Kernel function requires either prior knowledge
of the problem or some amount of trial and error. Also, while it has been claimed that
SVMs avoid, at least partially, the curse of dimensionality, this is generally false [16];
that is, SVMs suffer many of the same problems as other methods when the number
of inputs is proportionally much larger than the number of samples.
2.4 Variable selection methods
Both a gift and curse of microarray analysis is the vast amount of data that is gener-
ated. However, when thousands of genes are analyzed, and thus thousands of values
are generated for each sample, there are likely to many irrelevant genes which can
complicate the data analysis. In fact, in most cases there are only a few truly rel-
evant genes and thousands of irrelevant ones. With thousands of extraneous genes,
it is likely that some of these genes, due to chance and noise in the data, will be
highly correlated with the outcome variable but they are, in fact, completely unre-
lated. Sorting through the vast number of irrelevant genes to find the truly relevant
ones is not a trivial task.
The goal of variable selection in the analysis of gene expression matrices is two-fold.
First, variable selection allows models to be built using machine learning techniques
that are both simple and accurate. Even some of the more simple machine learning
methods cannot build a model using thousands of inputs in a reasonable amount of
time due to the massive amount of computation required; perhaps the only exceptions
is decision trees, which can handle a vast number of inputs because of the heavy
restrictions placed on the possible splits. However, even if a model could be built in a
reasonable amount of time using all of the available genes, the resulting model would
likely be overly complex and generalize poorly to new samples. Such a model would
likely be built using very small contributions from a large number of genes, making
the model highly sensitive to noise in the training set and therefore causing the model
to overfit the training data and generalize poorly. Furthermore, the resulting models
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will be more easily interpretable.
The second goal of variable selection in gene expression analysis is to discover the
genes that are most important to the problem being solved. This would allow further
research to be done on a limited number of genes, which could potentially help to
determine the role, if any, of theses genes in the disease or problem being studied.
Since microarray studies began in the late 1990's, a variety of different variable
selection methods have been tried. Since the field of microarray gene expression
analysis is in its infancy, there are few established methods for variable selection
and many of the methods used are seemingly ad hoc. Sections 2.4.1 through 2.4.3
describe a few methods that can be used for variable selection; these methods are
geared towards gene expression analysis.
2.4.1 Selection based on signal-to-noise ratio
Many variable selection techniques use some form of correlation between each gene
and the outcome variable. The genes are ranked according to their correlation with the
outcome variable, and a number of the most positively correlated genes are selected
along with a number of the most negatively correlated genes. In general, if N of the
most informative genes are desired, N positively correlated genes and 2 negatively2 2negatively
correlated genes are selected. This method for variable selection is attractive not only
because it retrieves the genes which are likely to be the most related to the outcome
variable, but also because the number of genes can easily be varied by simply selecting
fewer or more genes from the ranked list.
In what has become a seminal work on microarray data analysis, Golub et al used a
measure of correlation known as the signal-to-noise ratio (SNR) to select informative
genes. The SNR for a gene g is defined as
SNR(g) = g,1 - L9tg,2 (2.56)
rg,1 + Og9,2
where ,ug,i and ag,i are the mean expression level and the sample standard deviation,
respectively, of gene g for samples in class i. A positive value of SNR(g) means that
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gene g is more highly expressed in class 1, and, similarly, a negative value means
that g is more highly expressed in class 2. Furthermore, a large absolute value of
SNR(g) means that gene g is highly correlated with the outcome class. By using
the 25 genes with the most negative values of SNR(g) and the 25 genes with the
most positive values, Golub et al were able to build a model that could accurately
distinguish between acute myeloid leukemia and acute lymphoblastic leukemia [11].
A number of other measures exist for determining the correlation of each gene
with the outcome variable. For example, the t-statistic is similar to the SNR and is
defined as
t statistic(g) = '- g,2 (2.57)
2N + N2
where Atg,i and ua,i are again the mean expression level and the sample standard
deviation, respectively, of gene g for samples in class i and Ni is the number of
samples in class i [25]. Some authors believe that the Pearson correlation coefficient
is a reasonable choice for regression problems - or for classification problems, for that
matter - and is given by
r=- cy (2.58)
where crx and y are the sample standard deviations of x and y, and axy is the sample
covariance between the two [7], although there are several instances in which this
would not work.
The signal-to-noise ratio is used here over other correlation measures primarily
because of the success of the famous Golub et al study. The same method has proven
effective in more recent microarray analysis studies as well [28].
2.4.2 Selection based on Student's t tests and fold analysis
Many studies also use a Student's t test in combination with other discrimination
methods, such as fold analysis, as a means for variable selection [13, 15, 34]. A
Student's t test determines the probability p that two sets of measurements, each
sampled from a normal distribution, were actually sampled from the same normal
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distribution [10]. Here, the two sets of measurements are the gene expression levels
for a particular gene for samples of the first class and samples of the second class,
respectively. If the p value is low enough for a particular gene, there is a statistically
significant chance that the gene is differentially expressed between the two classes.
Generally, a test is considered statistically significant if p < .05.
There are drawbacks to using a Student's t test as the sole means for variable
selection. First of all, if the differential expression of a gene is considered statistically
significant if p < .05, then, in a gene expression matrix containing 10,000 irrelevant
genes, approximately 500 genes would be identified simply by chance; however, a
number of methods exist to mitigate this effect. Furthermore, using a Student's t
test may not be an appropriate approach because gene expression levels are generally
not normally distributed. When used, a Student's t test is often used in combination
with another selection method such that a variable is selected if and only if it has
a statistically significant p value and is also selected by the complimentary selection
method.
2.4.3 Stepwise variable selection
One of the benefits of using logistic regression to build a classifier model is that most
statistical software packages that support logistic regression also support stepwise
forward and backward variable selection. In stepwise forward variable selection, a
one-input model is built using each of the input variables. The models are then
ranked according to some criterion; in logistic regression, this is often the probability
p that the true variable coefficients are zero. The input variable that generates the
best one-input model is kept, and a two-input model is built using this input and
each of the other input variables. The additional input variable that generates the
best two-input model is kept, and this process continues until the number of inputs
in the model reaches some specified size [10]. Other criteria, such as cross validation
error or the Akaike Information Criterion (AIC), are also used in stepwise selection.
Stepwise backward variable selection in logistic regression works in the opposite
fashion. That is, a model is built using all inputs and the input variable is with the
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largest p value in the model is removed. Then, starting with the new model, the input
variable with the largest p value in the new model is removed. This process continues
until the number of input variables in the model reaches some set size or until the p
value of the next variable to be removed is below some threshold [10].
In the case of gene expression analysis, the number of input variables generally
needs to be reduced prior to using stepwise selection, so another form of variable
selection is first applied, followed by stepwise selection. Similar methods of stepwise
forward and backward selection can be applied to types of models other than logistic
regression, but software to perform such analysis is often not readily available.
2.5 Comparing model performance
When a large number of models are built using various machine learning techniques,
various parameter values, and various input variables, it is necessary to have stan-
dardized methods to compare the numerous models. A number of accepted methods
exist for both regression and classification models. Furthermore, there are methods
are available for right-censored survival data which allows even right-censored sam-
ples to be used in model comparisons; right-censored data and survival analysis are
discussed in Section 2.5.3. These methods can be used to evaluate model performance
using the training set as well as using a separate test set.
2.5.1 Evaluating regression models
Regression models are typically evaluated based on the model error, which is some
measure of the total or average difference between the model predictions and the
actual outcomes. The are a number of suitable error measures, but sum of squares is
most often used, and is given by
Error = E (f(xi) - yi)2 (2.59)
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The term in Equation (2.59) makes this an average error over the set of samples, so
that the performance of models on sets of varying sizes can be meaningfully compared.
2.5.2 Evaluating classification models
Accuracy - the proportion of samples classified correctly - seems like a natural and
intuitive measure of a classification models performance. However, there are a number
of drawbacks to using accuracy to evaluate classification models. First of all, accuracy
may be deceptive when there are significantly more samples in one class than the
other. For example, suppose that, in a set of patients, 1% of the patients have a
particular disease. Then, a completely uninformative model could simply classify all
patients as healthy and achieve a seemingly good 99% accuracy. Furthermore, even
if the number of samples in each class are relatively equal, reporting accuracy as a
measure for a model's performance doe not give any sense as to whether a model is
more likely to classify a sick person as healthy or a healthy person as sick. Therefore,
while accuracy, or perhaps misclassification cost, is a reasonable measure for the
performance of a multiple class classification problem, there are more informative
measures for two-class models.
Before discussing other performance measures for two-class classification models,
it is necessary to first give a few definitions. Suppose a data set consists of patients
from two classes; one class contains patients with a particular disease, also called the
sick patients, and the other class contains patients without that disease, also known
as the healthy patients. Then, for a given classification model, a true positive is a sick
patient that the model correctly classifies as sick; a false positive is a healthy patient
that the model incorrectly classifies as sick; a true negative is a healthy patient that
the model correctly diagnoses as healthy; and finally a false negative is a sick patient
that the model incorrectly diagnoses as healthy.
For medical diagnostic tests, and two-class classification models in general, per-
formance is often reported in terms of sensitivity and specificity. Sensitivity is defined
as the proportion of patients with the disease who are classified as sick, and can be
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calculated using the formula
(true positives)
(true positives) + (false negatives)'
Conversely, specificity is defined as the proportion of patients without the disease
who are classified as healthy, and can be calculated by
(true negatives)
(true negatives) + (false positives)'
Occasionally, the positive prediction value (PPV) and negative predictive value (NPV)
of a test or model are reported; these are defined as
PPV = (true (true positives) (2.62)
(true positives) + (false positives)'
~NPV (true negatives)
(true negatives) + (false negatives)'
In many cases, a diagnosis test or classification model has a continuous output,
and the cutoff point to determine which patients are sick and which are healthy
can often be varied. In general, the sensitivity and specificity of a test or model
vary inversely with one another; that is, as the cutoff point is changed to make a
test more sensitive, the test also generally becomes less specific and vice versa. A
receiver operating characteristic (ROC) curve is used to capture this tradeoff between
sensitivity and specificity. For a given test, an ROC curve plots (sensitivity) vs. (1 -
.specificity), and can be used to pick the appropriate cutoff point, taking into account
the misclassification costs. A 45° line is often included on the ROC plot because it
represents a completely uninformative test - that is, a test that performs no better
than one which randomly assigns patients to classes. The amount by which a test or
model's ROC curve is above the 45° line is a good indication of how informative or
powerful the test or model is. A test or model whose ROC curve consistently falls
below the 45° line can be made more powerful by simply reversing every prediction
the test or model makes. In this way, the area underneath the ROC curve, a value
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that is also known as the C-statistic, is a good measure of the performance of a test
of classification model. An ROC area of .5 means the particular model is completely
uninformative, while an ROC are of 1 means the model can perfectly discriminate
between the two classes.
In this paper, the performance of classification models will, in general, be reported
in terms of their ROC areas. However, because the problem being solved involves
right-censored survival, there are additional methods, discussed in Section 2.5.3,
which can make use of even the censored samples in the model evaluation.
2.5.3 Survival analysis
Survival analysis is concerned with the length of time it takes before each patient
suffers some event of interest; this event will be considered death for the rest of the
discussion on survival analysis, but could include a number of other things, such as
recurrence of a particular disease. Given a set of patients, a survival function, which
gives the probability a patient will survive to a given time, can be constructed as
S[t] =Mt (2.64)N'
where mt is the number of patients who have not died by time t, and N is the
total number of patients in the data set. Depending on the problem, time t can
be measured in, for example, hours, days, or months. In contrast to the survival
function, the cumulative mortality function gives the probability a patient will have
died by a given time, and is defined as
D[t] = 1 - S[t]. (2.65)
However, since the length of follow-up time with patients is often limited, some pa-
tients will still be alive when patient follow-up ends. These patients are said to
be right-censored. Without modification, the survival function in Equation (2.64)
would overestimate the probability of being alive at a given time, since some of the
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right-censored patients may have died by that time, without the data reflecting that
fact [10].
The Kaplan-Meier survival function is constructed in a different way from the
survival function given in Equation (2.64) and better approximates the true survival
probability when there are some right-censored samples. Let Pi be the probability of
dying during the ith time period, which can be calculated by
ni - di
Pi = , (2.66)ni
where ni is the number of patients at risk - that is, the number of patients that have
not yet died or been censored - at during time period i, and di is the number of
patients who die during this time period. Then, the Kaplan-Meier survival function
is is given by
S[t] = fpPt. (2.67)
i=O
Note that Pi = 1 for time periods during which patients do not die, so these values
are frequently omitted from Equation (2.67). The Kaplan-Meier cumulative mortality
function is then given by
D[t] = 1- S[t]. (2.68)
Most statistical software packages can calculate Kaplan-Meier curves, as well as their
corresponding confidence intervals. Note that the accuracy of Kaplan-Meier curves
decreases as time increases, because each estimate is based on fewer samples as
more samples become right-censored; equivalently, the confidence intervals around
the curves widen as time increases. A Kaplan-Meier survival curve accurately reflects
the underlying true survival curve if the patients are representative for the population
as a whole, and the censored patients have the same risk of dying as non-censored
patients [10].
Given two Kaplan-Meier survival curves, a test known as the logrank test can be
used to determine the probability p that the two curves were actually derived from
the same underlying survival function [10]. A logrank test can be used to evaluate
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the performance of a classification model. That is, two Kaplan-Meier survival curves
can be constructed, one for each of the two classes, as using the classification model
to place samples into the two classes; a lower p value between the two resulting
Kaplan-Meier curves means a model has found a more significant division of classes.
Similarly, a method derived from Cox proportional hazard regression can also be
used to evaluate classification models. Related to the survival function, the hazard
function A[t] is the instantaneous rate of death for patients in the data set. For a
small time period At, A[t]At can be seen as the probability that a patient who is alive
at time t will die by time t + At. The hazard function and the survival function are
related by
Sit] = e- fJA[]dx. (2.69)
Furthermore, two groups of patients are said to have proportional hazards if
Al = RAo, (2.70)
where Al1 and A0 are the hazard functions for the two groups, and R is called the
relative risk between the groups. A Cox proportional regression model assumes that
the ith patient has an instantaneous rate of death of the form
Xi = AoeEk 3kxik (2.71)
where Xik is the kth input variable for the ith patient and k is the coefficient for
this input variable. Similar to logistic regression, the value of ek is the relative
risk increase associated with a one unit increase in Xik. The probability p that each
coefficient p3 k is actually zero can be found using statistical software [10].
To use Cox hazard regression to compare models, xi in Equation (2.71) does not
contain the input variables for sample i; instead xi only contains a single binary
variable which denotes the class of sample i as predicted by a classification model.
Then, the p value for the coefficient o0 will equal the probability that samples from
the two predicted classes actually have the same relative risk; a lower p value means a
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model has found a more significant division of the two classes. Classification models
can be compared using this value of p in the same way that the models are compared
using the logrank p values; for the most part, the two tests produce similar results.
Note that, for either the logrank test or Cox proportional hazard regression, the
classification model being evaluated has found a statistically significant distinction
between groups if p < .05.
2.5.4 N-fold cross validation
When the training set is small, cross validation can be used to evaluate the perfor-
mance of various models. In cross validation, the training set is broken into K equally
sized sets. A model is built using K - 1 of these sets and is then tested using the
samples in the hold-out set. This process is repeated K times, with each set begin
used as the validation set once. The model performance is then reported as the total
performance - or sometimes the average performance - of the model on all of the
validation sets. In this way, each training sample is used both to build and test the
model, so the model can be evaluated without reducing the size of the training set.
In N-fold cross validation, also called leave-one-out cross validation, each valida-
tion set consists of only one sample. Thus, each model is built using all but one of
the training samples and is then used to predict the excluded sample. This process is
repeated so that each sample is used as the validation set once. N-fold cross validation
is particularly useful when the training set is extremely small, so that each model is
built using as many as possible of the available training samples.
In classification problems, cross validation performance is often reported as the
error rate - or, conversely, the accuracy - of the model when applied to the validation
samples. In regression problems, cross validation performance is typically reported
as the average sum of squares error of the validation samples.
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Chapter 3
Materials and Methods
This chapter describes the specific data set and software used in this paper, as well
as exact methods for variable selection, machine learning, and model comparison.
3.1 Mesothelioma data set
Collected at the Brigham and Women's Hospital (BWH) in Boston, the data set
used in this paper consisted of microarray gene expression data for 31 patients who
underwent an extrapleural pneumonectomy as a result of malignant pleural mesothe-
lioma, without additional preoperative treatment. A total of 60 tumor specimens
were collected; the remaining 29 samples were saved to be used as a test set for the
model built by the Gordon et al study [15]. Unfortunately, at the time this paper
was written, the data for this test set was unavailable. However, the data for these
additional samples would not have been very helpful to the current analysis since, for
the test set, only a select few genes were analyzed using the more precise method of
polymerase chain reaction; any model using any other genes would have been unable
to take advantage of the test set. The expression data was collected using Affymetrix
U95A chips and the resulting gene expression matrix was generated using Affymetrix
Microarray Suite, version 5. All of this preprocessing was done at BWH [14].
Note that the gene expression data set used by the Gordon et al study was gen-
erated using an earlier version of the Affymetrix Microarray Suite and therefore con-
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tained negative values for some of the expression levels. The matrix generated using
the newer version contains no negative values and so was preferable to the older data
set.
For two of the patients in the study, three separate microarrays were used to collect
expression information and so the gene expression matrix contained three separate
columns for each of the two samples. The median of the three values for each gene
expression level was used; using the median for each gene used more of the available
data than using only one of the three columns and was less sensitive to outliers and
incorrect values than using the mean would have been.
Each of the patients contained in the gene expression data was annotated with
several patient and tumor attributes in addition to the gene expression levels and
patient survival information. This additional information included patient age and
sex, as well as tumor stage and histology. The tumor histology described the tumor
subtype as epithelial, sarcomatoid, or mixed.
3.2 Recreating the results of Gordon et al
The first goal of this paper was to recreate and verify the results of the Gordon et
al study, using both the original data set and the newer data set - that is, the data
set generated with a newer version of the Affymetrix software. The Gordon et al
study built a predictive model based on the geometric mean of three ratios of gene
expression values. To recreate these results, the samples were first ranked according to
their survival. Patients with survivals in the 25th percentile or less and patients with
survivals in the 7 5 th percentile or more formed the poor and good outcome classes,
respectively.
For each gene, a two-tailed, unpaired Student't t test was performed between the
expression levels in the poor and good groups. A gene was considered informative if
it had a t test p value of less than .05, if the mean expression level in at least one of
the two groups was greater that 500, and if the mean expression level in one of the
two groups was at least twice that of the other group. The last two criteria seemed
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somewhat ad hoc, although the justification was that these criterion helped to select
genes which were less sensitive to noise [15]. This method of variable selection will
be referred to as the Gordon method.
From the list of informative genes, the four genes which were most statistically
significantly overexpressed in the poor outcome group - that is, the four genes with
the lowest t test p values among those whose mean expression level in the poor group
was at least twice that of the good group - and the four genes which were most
statistically significantly overexpressed in the good outcome group were used to form
sixteen ratios of genes overexpressed in the good group to those overexpressed in
the poor group. The resulting ratios were used to predict the classes of training
set samples. Using the most accurate of these ratios, new predictors were created by
calculating the geometric mean of all possible three ratio combinations. The resulting
predictors were again applied to the training set, and the most accurate were kept [15].
The analysis described in this paper, this process of choosing the good and poor
groups, selecting the informative genes based on these groups, and finally creating the
predictive ratios was performed on both the original data set and the newer data set.
Cross validation was performed in each case by leaving each of the training samples
out in turn, selecting genes and constructing the most accurate three ratio geometric
mean predictor with the remaining training samples, and using this predictor to
predict the outcome of the excluded sample [15]. Since the independent test set was
unavailable, the predictors were applied to the remaining samples in the data set that
were not used in the training set. However, since all of these samples have survivals
close to the median, they were the most difficult to predict and certainly were not
randomly chosen, so the performance on these samples was generally not indicative
of the ability of the models to generalize to new samples.
While the Gordon et al study achieved good results, both on the training set and
independent test set, their method used only 17 of the available 31 samples in training.
The analysis methods described in Section 3.3 divided the data set randomly into a
training and test set so that all samples could be used. For the classification problem
-- that is, trying to predict good or poor outcome based on dying before or after the
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median survival, respectively - 21 samples were used in the training set and ten were
left to use as a test set. For the regression problem - that is, predicting the actual
survival time - only 17 samples could be used in training set and six in the test set
because a number of the samples were right-censored.
All calculations used to recreate the results of Gordon et al were done in Microsoft
Excel.
3.3 Additional gene expression analysis
The second goal of this paper was to apply other variable selection and machine learn-
ing techniques to the same prediction problem that was studied by Gordon et al. Since
the independent test set was unavailable, as many as possible of the available samples
needed to be included in either the training or test sets. The analysis described in
this paper was concerned with building both classification models to classify samples
as being above or below the median survival and regression models to predict actual
survival in months; because many of the samples were right-censored, some are not
suitable for use in one or both types of models. In order to identify suitable samples,
first the median survival needed to be calculated. Of the 31 samples contained in
the gene expression matrix, a total of 8 were right-censored. The median survival
was calculated by first calculating the median for all of the uncensored samples and
then including each of the right-censored samples one by one, from the longest known
survival to the shortest, until the next censored sample to be added had a known
survival time less than the current median. This method used as much as possible
of the available data without biasing the calculation. The resulting median survival
was 11 months; this, for the classification problem, patients were considered to have
a poor outcome if they had survived less than 11 months and were considered to have
a good outcome if the survived for 11 months or longer. Only those samples that
were right-censored before reaching 11 months could not included in either the poor
or the good groups. A total of 28 samples were qualified for use in the classification
problem; the remaining three samples, which were right-censored prior to reaching the
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median survival, could only be used to construct Kaplan-Meier curves and compare
the various classification models using the logrank test.
For the regression problem, no right-censored samples could be included in either
the training or test set, because doing so would have biased the results. Thus, a total
of 23 samples were suitable for use in the regression problem.
The unavailability of an independent test set necessitated that the already small
data set be separated into a training set and an independent test set. Seven samples
were excluded from the samples suitable for the classification problem to be used as
a test set, resulting in a training set of 21 samples. While this training set is small, it
still four samples larger than the training set used by Gordon et al. Six of the excluded
samples were also samples suitable for regression, leaving a total of 17 samples for
use in regression training. Thus, the training sets for classification and for regression
were as similar to one another as possible. To choose the specific training and test
sets, the training and test set labels were randomly permuted until the absolute value
of the correlation between the training set label and the good or poor outcome label
for classification samples was less than .05 and the absolute value of the correlation
between the training set label and the survival outcome for regression samples was
also less than .05.
All of the analysis methods described in this section and in Sections 3.3.1 through 3.3.3
used the newer data set since it contained no negative expression level values.
3.3.1 Variable selection
In addition to being used to recreate the results of Gordon et al, the Gordon method
of variable selection described in Section 3.2 was applied to the new training set; the
set of selected genes was used as inputs to a variety machine learning methods to
generate predictive models.
In contrast to the Gordon et al study, Golub et al ranked genes according to
the signal-to-noise ratio (SNR) of the log expression values. In keeping with this
approach, the logarithm of all of the expression levels were calculated; the SNR was
calculated for each gene using the training samples. Genes were ranked according to
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the resulting SNR values and this ranking was used to select genes as inputs for the
machine learning methods used. When N genes were needed, the genes with the
most positive values and the N genes with the most negative values of the SNR were
selected. This method of gene selection will be referred to as the Golub method. A
total of four gene sets were generated using the Golub method, containing the best
4, 10, 30, and 50 genes, respectively.
Although there was some justification, the choice of 4, 10, 30, and 50 genes was
somewhat arbitrary. A gene set with 50 genes was chosen as the largest set because
using significantly more than this number of genes maked the computation time,
especially in neural networks, prohibitively long; Golub et al also used a total of
50 genes in their predictive model [11]. Similarly, the gene set with 4 genes was
chosen because Gordon em et al used only 4 genes in their prognostic predictor of
mesothelioma [15]. Sets with 10 and 30 genes were reasonable compromises between
the two extremes.
A total of five different gene sets - the one using the Gordon method and the four
using the Golub method - were generated to use as inputs to the machine learning
methods. In order to examine the effects of the additional patient information -
such as age, sex, tumor subtype and tumor histology - on the performance of the
of constructed models, two input variable sets were generated for each gene set,
one containing the additional patient information and one without these additional
variables. Thus, a total of ten different input variable sets were generated to use in
all the types of machine learning.
Lastly, although decision trees can handle a large number of input variables, with
over 12,000 total genes in the gene expression matrix, it is necessary to reduce the
number of inputs to speed up computations and reduce the chance of finding irrelevant
genes that produce good splits. Thus, an input variable set containing the 500 genes
with the lowest Student's t test p values, which included all genes with a p value of
less than .05, was also generated to use to build a decision tree model.
All calculations needed for variable selection were done using Microsoft Excel.
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3.3.2 Machine learning
Classification trees were built using each of the ten different input variable sets and
N-fold cross validation was performed to assess the ability of the trees to generalize
to new inputs. A tree was also built using the 500 genes with the lowest Student's
t test p values. Each tree was built until the leaf nodes were completely pure and
no pruning was performed. The best classification tree model, based on the cross
validation error rate, was then applied to the independent test set; if two or more
trees had the same error rate, the one based on the fewest input variables was chosen.
Classification trees were built using the demonstration version of See5, release
1.20a. This software was unable to handle regression trees.
Four neural networks for classification were trained for each of the ten input
variable sets. All neural networks used batch learning with a learning rate of .25 and
a momentum coefficient of .9 and all networks were training for a total of 500 epochs.
All the networks used hyperbolic tangent activation functions in both the hidden and
output layers; the hyperbolic tangent function was chosen over the sigmoid function
because networks with hyperbolic tangent activation functions trained faster than
those using sigmoid activations. All inputs, including both gene expression levels
and additional patient information variables, were standardized to have zero mean
and one variance, and the initial network weights were generated from the uniform
distribution ranging from -.7 to .7. This initial weight distribution generally produces
good results when the inputs are standardized [16].
One of the four neural networks trained for each input variable set contained eight
hidden neurons and used no regularization; the relatively large number of hidden
neurons presumably allowed every training set to be perfectly modeled. The second
network used only two hidden neurons and had no regularization; the small size of this
network presumably forced the model to assume a simpler structure and thus avoided
overfitting the training set. The final two networks used eight hidden neurons,but
used weight decay regularization with v coefficients of .5 and 2.5, respectively, to
avoid overfitting.
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N-fold cross validation was used to assess the performance of each network. Since
the neural networks produced continuous results, the cutoff value to determine which
samples were predicted as poor and which were predicted as good could be varied
to change the sensitivity and specificity of the network. For each of the N networks
used in N-fold cross validation, this cutoff value was chosen to maximize the sum
of the training set sensitivity and specificity and the excluded training sample was
predicted using this cutoff value. Since the neural network cross validation results
were due, in part, to the random starting weights of the networks, cross validation was
performed five separate times for each network configuration and the resulting error
rates were averaged. The best neural network configuration, based on the average
cross validation error rate, was then applied to the independent test set; if two or more
neural networks had the same average error rate, the one based on the fewest number
of inputs, with the smallest structure, or with the highest regularization coefficient
was chosen.
Four neural networks for the regression problem were also created using each of
the ten input variable sets. These four networks used the same parameters as those
used for the classification problem, except linear activation functions were used in
the output neurons. N-fold cross validation was then used to find the average sum of
squares error for each network. The N-fold cross validation was applied a total of five
times and the resulting error values were averaged, thus helping to reduce variance
in the cross validation error due to the random starting weights of the networks.
The best network in terms of average cross validation error was then applied to the
independent test set.
All of the neural networks used in this paper were created using GAINN software
written by Jonathan Jackson [19]; minor modifications were necessary in order to
perform all of the required calculations.
Four support vector machines were generated for each of the ten input variable
sets, using a linear kernel, a degree-two polynomial kernel, a degree-four polynomial
kernel, and a radial kernel, respectively. All of the support vector machines were
created using SVMight software, version 6.01, with learning module 01.09.04. As in
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the case of neural networks, each input was standardized to have zero mean and one
variance. The default value of the regularization coefficient, which is set dynamically
by the software based on the choice of kernel function, was chosen in all cases and
estimates of the cross validation error for each SVM were produced automatically by
the software. The best SVM, based on the estimated cross validation error rate, was
then applied to the independent test set; if two or more support vector machines had
the same estimated error rate, the one based on the fewest input variables or with
the simplest kernel function was chosen.
A logistic regression model was also generated using each of the ten data sets. The
gene expression level inputs were standardized to have zero mean and one variance.
N-fold cross validation was done by constructing a logistic regression model with the
included 20 samples and predicting the class of the excluded sample using .5 as a
cutoff between the poor and good classes. Additionally, logistic regression models
were built using stepwise forward and backward variable selection with a p value
threshold of .25 for inclusion or exclusion. N-fold cross validation was also done for
the stepwise logistic regression models. Due to the limited number of samples in the
training set, the software was unable to perform stepwise variable selection for the
larger input variable sets. The best logistic regression model based on cross validation
error rate was then applied to the independent test set.
All logistic regression calculations were done using Intercooled Stata for UNIX,
version 8.2.
3.3.3 Model comparisons using the test set
A total of four models - the best classification tree, neural network, support vector
machine, and logistic regression model, based on cross validation performance - were
applied to the independent classification test set. The sensitivity and specificity was
calculated for each of these models based on the seven test samples that were not
right-censored prior to the median survival. Furthermore, using these seven samples
and the three samples that were right-censored prior to the median survival, two
Kaplan-Meier curves were constructed for each model based on the predicted class;
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the logrank test for these two curves was then calculated.
One model, the best neural network regression model, was applied to the indepen-
dent regression test set. Results were given in terms of the average sum of squares
error for the six test cases.
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Chapter 4
Results and Discussion
This chapter presents and discusses the results from the various analyses which were
performed. Section 4.1 presents the results from recreating the Gordon et al analysis,
using both the original data set and the newer data set generated with a more recent
version of Affymetrix software. Section 4.2 presents the results from the additional
variable selection and modeling analyses performed. Lastly, Section 4.3 provides a
discussion of these results.
4.1 Recreated results of Gordon et al
A total of 17 samples were included in the training set used by the Gordon et al
study; nine of these samples had poor outcomes and eight had good outcomes. The
complete list of all 17 samples is given in Table 4.1. It is interesting that sample
34 was not included in this training set. This patient had a survival of 34 months,
well above the 7 5th percentile, and, although it was right-censored, there were several
other right-censored samples in the training set. In order to recreate their results
exactly, this sample was excluded from the training set in this analysis.
Using this training set, the Gordon method of variable selection, described in
Section 3.2, identified a total of 46 differentially expressed genes, 24 of which were
overexpressed in the good outcome group and 22 of which were overexpressed in the
poor outcome group. The full list of identified genes is given in Table 4.2.
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Table 4.1: Set of training
Patient age at
diagnosis, yr
51
69
62
55
33
39
55
66
49
67
62
60
61
44
48
40
46
Sex
M
M
M
M
F
M
M
M
F
M
M
F
M
F
M
F
M
samples used by the
Tumor Tumor
histologya stage
mixed 2
mixed 2
sarc 2
mixed 2
ept 2
ept 2
mixed 2
sarc 2
ept 2
ept 1
ept 2
ept 2
ept 2
ept 2
ept 2
ept 1
mixed 2
Gordon et al study
Patient Patient
survival, mon statusb
2 3
2 3
2 3
3 3
5 3
5 3
6 3
6 3
6 3
17 3
19 3
20 3
21 3
26 2
28 2
51 2
53 3
aFor tumor histology, ept = epithelial and sarc = sarcomatoid.
bFor patient status, 1 = alive without mesothelioma, 2 = alive with mesothelioma, 3 = dead from
mesothelioma, 4 = dead from other causes and U = unknown [15].
The four most statistically significantly overexpressed genes in the good group and
the four most statistically significantly overexpressed genes in the poor group were
used to construct 16 ratios, using all possible combinations with one gene from each
group of four. The resulting ratios were used to predict the classes of the training
samples; a sample was considered good if the ratio was greater than one and was
considered poor if the ratio was less than one. The full list of calculated ratios and
their accuracies on the training set are given in Table 4.3. A total of five such ratios
had an accuracy of 88% in classifying the training set, and the 16 ratios had an
average accuracy of 77%. Since no expression level standardization - for example,
converting every gene expression level to have zero mean and one variance - was done
in this analysis, it is interesting that this method works so well to predict the training
set. For example, without expression level standardization, a sample could have a
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Sample
No.
114
133
159
89
22
6
130
166
67
76
109
33
68
2
90
74
72
-__
I-
Table 4.2: Genes identified by the Gordon et al study
Description
Selenium binding protein 1
KIAA0977 protein
Zinc finger protein 151 (pHZ-67)
Protein tyrosine phosphatase
Hyaluronan synthase 1
I factor (complement)
BCG-induced gene in monocytes, clone 103
Histone 1, H2bk
Sema domain, immunoglobulin domain (Ig)
Cytochrome b-5
Transmembrane 4 superfamily member 1
DKFZP586H2123 protein
Alcohol dehydrogenase 1A
Retinoic acid receptor responder
Phospholipase A2, group IIA
Sulfotransferase family
Retinoic acid receptor responder
Carboxypeptidase B1 (tissue)
Poly(rC) binding protein 2
Calbindin 2, 29kDa (calretinin)
Histone 2, H2aa
Secretory leukocyte protease inhibitor
Kallikrein 11
KIAA1055 protein
Pyruvate kinase, muscle
S100 calcium binding protein All (calgizzarin)
Rho GDP dissociation inhibitor (GDI) alpha
Transgelin
MLL septin-like fusion
Zyxin
Apolipoprotein C-I
PDZ and LIM domain 1 (elfin)
Insulin-like growth factor binding protein 3
Plectin
Actinin, alpha 1
Actin, alpha 2, smooth muscle, aorta
Keratin 18
Complement component 1, q subcomponent
Tubulin, beta, 5
Keratin 8
LIM domain only 4
Collagen, type IV, alpha 2
Midkine (neurite growth-promoting factor 2)
Myosin, light polypeptide 9, regulatory
Insulin-like growth factor binding protein 4
Ratio of Student's
good to t test
poor mean p value
2.8 0.0033
2.1 0.0065
3.0 0.0073
2.0 0.0077
6.0 0.0094
3.6 0.0103
3.7 0.0103
3.5 0.0142
2.3 0.0181
2.5 0.0182
2.8 0.0256
2.1 0.0257
14.8 0.0288
3.4 0.0291
2.7 0.0302
2.3 0.0305
3.7 0.0327
4.5 0.0329
2.2 0.0368
2.3 0.0390
2.2 0.0439
2.9 0.0461
2.3 0.0483
2.1 0.0496
0.38 0.0013
0.43 0.0041
0.35 0.0046
0.47 0.0063
0.33 0.0068
0.49 0.0069
0.43 0.0105
0.40 0.0131
0.49 0.0132
0.30 0.0135
0.33 0.0170
0.40 0.0216
0.42 0.0234
0.46 0.0234
0.48 0.0238
0.44 0.0286
0.38 0.0288
0.43 0.0324
0.25 0.0371
0.28 0.0375
0.29 0.0399
0.34 0.0456
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Probe
ID
37405_at
41755_at
41531_at
36204_at
32424at
35698_at
40456_at
32819_at
376_at
38459_gat
892_at
40016_gat
34637_fat
33505_at
37017_at
32317_sat
1042_at
41210_at
35754_at
37157_at
286_at
32275_at
40035 at
39400_at
32378_at
38138_at
1586_at
40164_at
36931 at
41220_at
36958_at
41764_at
36937-_at
37319_at
38021 at
39330sat
32755_at
35766_at
38796_at
429_f-at
33824_at
1451 sat
36659_at
38124at
39145_at
1737s_at
Gene
sequence
No.
U29091
AB023194
Y09723
Y00815
D84424
Y00318
AL049963
AJ223352
AB000220
L39945
M90657
AL050214
M12963
AI887421
M22430
U34804
U27185
M81057
X78136
X56667
L19779
X04470
AB012917
AB028978
M26252
D38583
M35878
X69550
M95787
AB023208
X95735
AA976838
U90878
M35878
U53204
M95178
X13839
M26326
X03084
X00734
X74929
U24576
X05610
X55110
J02854
M62403
-
- -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
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Table 4.3: Ratio predictors and corresponding accuracies for the original Gordon et
al data set
Gene
overexpressed
in good
41531_ at
41755_at
41755_at
41531 at
36204_at
41755_at
36204_at
37405_at
36204_at
37405_at
41531 at
37405_at
41531 at
36204_at
41755_at
32378_at
Gene
overexpressed
in poor
32378_at
1586_at
40164_at
40164_at
40164_at
38138_at
38138_at
1586_at
1586_at
40164_at
38138_at
32378_at
1586_at
32378_at
32378_at
38138_at
Training
set
accuracy, %
88.2
88.2
88.2
88.2
88.2
82.4
82.4
82.4
82.4
82.4
76.5
70.6
70.6
58.8
52.9
47.1
gene that was related to good prognosis expressed at levels above its mean and a gene
related to poor prognosis expressed below its mean, but if the overall means of these
two genes were very different, the sample could still have a ratio of less than one. The
fact that this method works so well without data standardization may be a result of
the seemingly ad hoc restrictions placed on the genes in the variable selection process.
Using only the five most accurate individual ratios, new predictors were formed
by taking the geometric mean of every possible combination of three ratios. Again,
the training samples were classified using these predictors such that a sample was
predicted to have a good prognosis if the predictor value was greater than one. The
ten predictors had an average accuracy of 94% and none had an accuracy of less than
that of the best single ratio accuracy. Two of the resulting geometric mean predictors
achieved 100% accuracy on the training samples. The list of ten predictors and their
accuracies in predicting the training samples are given in Table 4.4; the first predictor
70
Table 4.4: Geometric mean predictors and corresponding accuracies for the original
Gordon et al data set
Ratio 1 Ratio 2 Ratio 3 Training
Good Poor
gene gene
41531_at 32378_at
41531_at 32378_at
41531_at 32378_at
41531_at 32378_at
41755_at 1586_at
41755_at 1586_at
41755_at 40164at
41531_at 32378_at
41531_at 32378_at
41755at 1586_at
Good Poor
gene gene
41755_at 40164_at
41755_at 1586_at
41755_at 40164_at
41531_at 40164_at
41755_at 40164_at
41531_at 40164_at
41531_at 40164_at
41755at 1586_at
41755_at 1586_at
41755_at 40164_at
Good Poor
gene gene
41531_at 40164_at
41755_at 40164_at
36204at 40164_at
36204at 40164_at
36204_at 40164_at
36204_at 40164_at
36204at 40164_at
41531_at 40164_at
36204_at 40164_at
41531_at 40164_at
set
accuracy, %
100.00
100.00
94.12
94.12
94.12
94.12
94.12
88.24
88.24
88.24
listed is the one selected by Gordon et al to test on the independent test set. Note
that neither of two most accurate ratios predicted the remaining ten samples excluded
from the training set - which did not include the four samples right-censored prior
to the median - with an accuracy of greater than 27%, using the median survival of
11 months as the cutoff between poor and good groups. However, this accuracy was
not a good measure of the ability of these ratios to generalize to new samples, since
these remaining samples could not be considered randomly selected; they tended to
have survivals clustered close to the mean and thus were likely to be the most difficult
samples to predict.
All of these reported results were generated specifically for this paper and matched
the results of Gordon et al exactly.
The N-fold cross validation error rate was then calculated for this type of model.
That is, one training sample was excluded and the variables were selected using the
Gordon method with the remaining 16 training samples. The four most statistically
significantly overexpressed genes in each of the two classes were used to create 16 ratio
predictors, the three most accurate of which were then used to form one geometric
mean predictor; the resulting predictor was then used to predict the remaining sam-
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pie. This process was repeated a total of 17 times, with each training sample being
excluded once. In many cases, there were more than three equally accurate individual
ratios; in this case, geometric mean predictors were created using all combinations of
three ratios and the class of the excluded sample was determined by a majority vote
of these predictors.
Gordon et al reported an 88% accuracy using this process; however, only a 65%
accuracy was calculated in the recreation of their results. Gordon et al were somewhat
vague in their description of the cross validation process, so it is possible that the
discrepancy in the reported results was due to slight differences in exact methods
used. This could have included, for example, how the excluded sample was predicted
when more than three ratios are equally accurate. It is also possible that there
were differences in the data set used in the current analysis from the data set used
by Gordon et al. These errors could have come from a number of sources, such
as transcription errors or the matrix being improperly sorted. However, since all the
other values, including Student's t test p values and mean expression level ratios, were
identical to those reported by Gordon et al and since the data set used in this paper
was obtained directly from researchers at BWH, it is unlike that the discrepancy in
the reported cross validation error rates was caused by data set errors.
However, another discrepancy arose when recreating other results of Gordon et al.
Since the epithelial subtype is associated with relatively good patient outcome, Gor-
don et al performed a logrank test on two Kaplan-Meier curves containing epithelial
samples and non-epithelial samples, respectively, to determine the statistical signifi-
cance of the difference in survival between these two groups of patients. In recreating
these results, the constructed Kaplan-Meier curves were different from those pub-
lished in the Gordon et al paper. The two Kaplan-Meier curves constructed in the
current analysis are shown in Figure 4-1. Of course, since the Kaplan-Meier curves
were different, the logrank p values were different as well; Gordon et al reported a p
value of .129, while the current analysis found a p value of .399.
While there may have been errors in the data set, this represented a mistake by
Gordon et al. In their paper, they listed the set of training samples with patient and
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0Figure 4-1: Kaplan-Meier survival curves based on tumor histology.
tumor information; this set included the patient with the longest known survival of
54 months - sample number 72 - who also happened to have a mixed subtype tumor.
However, this patient was clearly included in the epithelial subtype Kaplan-Meier
curve [15] when the patient should have been included in the non-epithelial subtype.
However, this was not a serious mistake by any means and did not affect their end
results.
4.1.1 Recreated results using the newer data set
After recreating and verifying the results of Gordon et al on the original data set,
the same process was repeated on the newer data set, generated with a more recent
version of Affymetrix Microarray Suite software. This newer data set contained the
same samples and patient information; only the expression levels were different. The
same 17 samples were used as a training set and the same method for selecting
variables and building ratio-based predictors was used. In this case, only 29 genes
were identified as differentially expressed; these genes are listed in Table 4.5. Of
these 29 genes, 24 were also identified by the original Gordon et al. The four most
statistically significantly overexpressed genes in each group were then used to form
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16 expression level ratios; these ratios were then used to predict the classes of the
training set samples. The ratios formed using the newer data set and their accuracies
in predicting the training set are listed in Table 4.6. Of the eight genes used to build
these ratios, only two genes - genes with probe identification numbers of 32378_at
and 40164_at, respectively - overlapped with the eight genes from the original data
set; since both of these genes were overexpressed in the poor group, none of the same
ratios from Table 4.6 were included in the analysis on the original data set. Therefore,
none of the predictors built using the newer data set were the same as the predictors
built using the original data set.
With the newer data set, one ratio had an accuracy of 94%, better than any of the
individual ratios using the original data set, and seven others predicted the training set
with 88% accuracy. New predictors were built using the geometric means of the most
accurate ratio and every possible combination of two of the seven next most accurate
ratios. The resulting 21 predictors are listed in Table 4.7. Unlike the geometric means
built using the original data set, none of these had a training set accuracy of 100%,
although they did perform very well with an average accuracy of 89%. Even using
all possible three ratio combinations did not produce a single predictor with 100%
accuracy on the training set; these results are not presented. None of the five best
predictors, which all had a training set accuracy of 94%, predicted the remaining
samples - not including samples which were right-censored prior to the median -
with greater than a 36% accuracy; again, however, this is not a good indication of
the ability of any of these ratio-based predictors to generalize to new samples.
The same method for calculating the N-fold cross validation error rate was then
applied to the newer data set. The N-fold cross validation accuracy was calculated as
65%, the same as in the original data set. Thus, the ratio-based method was equally
accurate, in terms of cross validation, in both the original data set and the newer
data set.
It would be very informative to be able test one or more of the most accurate pre-
dictors listed in Table 4.7 against the predictor used by Gordon et al. Unfortunately,
an independent test set is unavailable. The results on the newer data set do seem
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Table 4.5: Genes identified by Gordon method using original training set and new
data set
Gene Ratio of Student's
Probe sequence good to t test
ID No. Description poor mean p value
37405_at U29091 Selenium binding protein 1 2.8 0.0036
32424_at D84424 Hyaluronan synthase 1 3.4 0.0080
41210_at M81057 Carboxypeptidase B1 (tissue) 4.3 0.0209
892_at M90657 Transmembrane 4 superfamily member 1 2.6 0.0314
376_at AB000220 Sema domain, immunoglobulin domain 2.3 0.0339
40456_at AL049963 BCG-induced gene in monocytes, clone 103 3.1 0.0375
41531 at AI445461 Transmembrane 4 superfamily member 1 2.7 0.0405
37157_at X56667 Calbindin 2, 29kDa (calretinin) 2.3 0.0406
33505_at AI887421 Retinoic acid receptor responder 3.6 0.0434
34637_f-at M12963 Alcohol dehydrogenase 1A 13.2 0.0485
32378_at M26252 Pyruvate kinase, muscle 0.41 0.0001
40164_at X69550 Rho GDP dissociation inhibitor 0.44 0.0015
36958_at X95735 Zyxin 0.49 0.0030
36931 at M95787 Transgelin 0.37 0.0044
39330sat M95178 Actinin, alpha 1 0.40 0.0083
32755_at X13839 Actin, alpha 2, smooth muscle, aorta 0.36 0.0127
39145_at J02854 Myosin, light polypeptide 9, regulatory 0.38 0.0142
35766_at M26326 Keratin 18 0.42 0.0149
38796_at X03084 Complement component 1, q subcomponent 0.46 0.0162
37319_at M35878 Insulin-like growth factor binding protein 3 0.31 0.0244
35905_sat U34995 Glyceraldehyde-3-phosphate dehydrogenase 0.46 0.0253
33824_at X74929 Keratin 8 0.50 0.0278
1451_sat D13666 Osteoblast specific factor 2 (fasciclin I-like) 0.38 0.0308
36659_at X05610 Collagen, type IV, alpha 2 0.25 0.0310
1664_at HG3543-HT3739 - 0.30 0.0390
1737_sat M62403 Insulin-like growth factor binding protein 4 0.30 0.0409
769_sat D00017 Annexin A2 0.50 0.0439
38418_at X59798 Cyclin D1 0.39 0.0448
36675rat J03191 Profilin 1 0.49 0.0483
very comparable to the results on the original data set; for example, the ratio-based
predictor list at the top of Table 4.7 uses two of the same genes as the ratio-based
predictor used and tested by the Gordon et al study and only two new genes. N-fold
cross validation gives an identical error rate between the two data sets, and, although
none of the geometric mean predictors predicted the training set in the newer data
set with 100% accuracy, the accuracies of the individual ratios and geometric mean
predictors are very similar between the two data sets. In fact, the most accurate
individual ratio in the newer data set was more accurate than the most accurate in-
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Table 4.6: Ratio predictors and corresponding accuracies for the newer data set
Gene
overexpressed
in good
37405_at
892_at
32424_at
892_at
37405_at
32424_at
892_at
37405_at
32424_at
37405_at
41210 at
41210 at
892_at
41210 at
41210 at
32424_at
Gene
overexpressed
in poor
40164_at
32378_at
40164_at
40164_at
36958_at
36958_at
36958_at
36931 at
36931 at
32378_at
40164_at
36958_at
36931 at
32378_at
36931 at
32378at
Training
set
accuracy, %
94.1
88.2
88.2
88.2
88.2
88.2
88.2
88.2
82.4
76.5
76.5
76.5
76.5
64.7
64.7
52.9
dividual ratio in the original data set. While Gordon et al may have found a good
predictive model, ratio-based models from the newer data set may perform as well
or better as the original model, since the data used to generate these newer models
was created using a newer and presumably more precise method of calculating gene
expression levels from microarray slides. Only an additional two genes - those with
probe identification numbers of 37405_at and 892_at, respectively - would need to be
analyzed using PCR in order to test one of the newer ratio-based predictors. Note
that, although there is a chance that the probe identification numbers for various
genes changed between the two data sets, the list of probe identification numbers
and corresponding genes cited from the author's website [12] and the equivalent list
obtained directly from researchers at BWH were equivalent for a number of randomly
selected genes; thus, it is likely that the probe identification numbers did not change
between the two data sets.
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Table 4.7: Geometric mean predictors and corresponding accuracies for the newer
data set
Ratio 1
Good Poor
gene gene
37405_at
37405_at
37405_at
37405_at
37405-at
37405_at
37405-at
37405_at
37405_at
37405_at
37405_at
37405_at
37405_at
37405_at
37405_at
37405_at
37405_at
37405_at
37405_at
37405_at
37405_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
40164_at
Ratio 2
Good
gene
892_at
892_at
892 at
32424_at
892_at
892_at
892_at
892_at
32424_at
32424_at
892 at
892_at
892_at
37405_at
37405_at
37405_at
32424_at
32424_at
892_at
32424_at
32424_at
Poor
gene
32378_at
32378_at
32378_at
40164_at
40164_at
32378_at
32378_at
32378_at
40164_at
40164_at
40164_at
40164_at
40164_at
36958_at
36958at
36958_at
36958_at
36958_at
36958_at
40164_at
40164_at
Ratio 3
Good
gene
892_at
32424_at
892_at
37405_at
37405_at
32424_at
37405_at
37405_at
32424_at
892_at
32424_at
892_at
37405_at
32424_at
892_at
37405_at
892_at
37405_at
37405_at
892_at
37405_at
Poor
gene
40164_at
36958_at
36958_at
36931_at
36958_at
40164_at
36958_at
36931 at
36958_at
36958_at
36958_at
36958_at
36931 at
36958_at
36958_at
36931 at
36958_at
36931 at
36931 at
40164_at
36958_at
Training
set
accuracy, %
94.1
94.1
94.1
94.1
94.1
88.2
88.2
88.2
88.2
88.2
88.2
88.2
88.2
88.2
88.2
88.2
88.2
88.2
88.2
82.4
82.4
4.2 Results of additional analysis
Additional analyses were performed to identify other differentially expressed genes
and build predictive models for survival in patients with malignant pleural mesothe-
lioma. The absence of an independent test set dictated that the data set be split into
training and test sets in such a way as to use as much as possible of the available
data. Thus, a training set with 21 patients was randomly generated from the suitable
samples; eleven of these samples had a good outcome - that is, a survival of 11 of
more months - and ten had a poor outcome. Seven of the remaining samples were
used as a test set and the final three samples, which were right-censored prior to the
median survival, were left to be used in logrank tests. The training set, test set, and
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set to be used in logrank tests are shown in Table 4.8; these sets were used in all of
the additional analyses. All of the additional analyses used expression levels from the
newer data set.
4.2.1 Results of variable selection
The top 50 genes, 25 of which were overexpressed in each of the two outcome classes,
as identified by the Golub method of variable selection are listed in Table 4.9. Inter-
estingly, none of the these 50 genes were the same as any of the 46 genes identified by
the original Gordon et al study or any of the 29 genes identified by recreating their
results using the newer data set.
Applying the Gordon method of variable selection to the new training set identified
a total of nine genes; these are listed in Table 4.10. Two of these genes were also
identified by the original Gordon et al study, although neither of these genes was
among the eight used to build the ratio-based predictors. Likewise, one of the genes
listed in Table 4.10 was also identified by the recreated Gordon et al results on the
newer data set but again was not among the eight used to build the predictive models.
Lastly, none of these nine genes were among the top 50 genes as identified by the Golub
method.
It appears that the Gordon method of variable selection is not well suited for use
on randomly selected training sets. When applied to the new training set, the method
identified only nine genes and only two of these genes were overexpressed in the poor
outcome group. This method of variable selection seems to work best when only the
best and worst samples are used for training; for many of the genes, the samples
with survivals close to the median must pull the mean of the expression levels in each
group closer to the overall mean, thus causing the method to identify fewer genes.
4.2.2 Cross validation results from machine learning models
The N-fold cross validation error rates for classification trees are shown in Table 4.11.
Notice that, for the Golub set containing 4, 10, and 30 genes, both with and without
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Table 4.8: Samples used in training and test sets for additional analysis
Patient age at
diagnosis, yr
Tumor Tumor
Sex histology stage
Patient Patient
survival, mo statusa
51
62
55
33
39
55
66
49
53
42
55
71
49
52
67
62
60
44
48
40
46
Training set
M mixed
M sarc
M mixed
F ept
M ept
M mixed
M sarc
F ept
M ept
F ept
M mixed
F ept
M mixed
M ept
M ept
M ept
F ept
F ept
M ept
F ept
M mixed
2
2
3
5
5
6
6
6
7
9
11
11
13
15
17
19
20
26
28
51
53
3
3
3
3
3
3
3
3
3
3
11
3
3
3
3
3
3
21
21
21
3
Test set
133 69 M mixed 2 2 3
57 61 M ept 2 7 3
42 64 M mixed 1 10 3
105 66 M mixed 2 12 3
212 62 F mixed 2 12 3
68 61 M ept 2 21 3
34 52 F mixed 2 34 41
Right-censored samples used for logrank test
82 68 F mixed 2 1 41
118 74 M mixed 2 7 41
116 70 M ept 2 9 U1
aFor patient status, 1 = alive without mesothelioma, 2 = alive with mesothelioma, 3
mesothelioma, 4 = dead from other causes and U = unknown [15].
aRight-censored samples are excluded from regression analysis.
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= dead from
Sample
No.
114
159
89
229
6
130
166
67
167
86
213
101
51
93
76
109
33
2
90
74
72
-
Table 4.9: Top 50 genes identified by Golub method using new training set
Probe Gene
ID Seq. No. Description SNR
32629_f-at U90552 Butyrophilin, subfamily 3, member Al 1.042596
33428_sat AF034957 Attractin 1.035815
37973_at AB018256 Sorting nexin 13 0.875127
41174_at AF012086 Similar to RAN-binding protein 2 0.841515
39414_at L23849 - 0.839765
31315_at D84143 Homo sapiens immunoglobulin lambda light chain 0.83609
304_at HG961-HT961 - 0.823303
40060_rat AF061258 LIM protein 0.792319
35475_at U37251 Zinc finger protein 177 0.768456
36072_at AF025770 Zinc finger protein 189 0.76337
31413_at AF000990 Testis-specific transcript, Y-linked 1 0.758292
37288_gat U55258 Neuronal cell adhesion molecule 0.756127
40743_at M60092 Adenosine monophosphate deaminase 1 0.753599
39815_at AA883101 Secreted protein of unknown function 0.739854
37142_at AF038421 GDNF family receptor alpha 1 0.731596
636_at L43338 - 0.720407
39440_f-at AA962207 - 0.717747
40606_at U88629 ELL-related RNA polymerase II, elongation factor 0.716377
39980_at AB000449 Vaccinia related kinase 1 0.710041
1895_at J04111 - 0.698625
40292_at AF027734 Deleted in bladder cancer chromosome region candidate 1 0.694958
35783_at H93123 Vesicle-associated membrane protein 3 0.693607
35549_at L05096 Ribosomal protein L39-like 0.692348
35071sat AF042377 GDP-mannose 4,6-dehydratase 0.691798
36501_at S87759 Protein phosphatase 1A 0.690801
40489_at D31840 Dentatorubral-pallidoluysian atrophy (atrophin-1) -1.08847
35151_at AF089814 Tumor suppressor deleted in oral cancer-related 1 -1.0085
38729_at M88279 FK506 binding protein 4, 59kDa -0.96146
33285_iat W26762 Hypothetical protein FLJ21168 -0.86635
34541_at L02867 Paraneoplastic antigen 
-0.86036
37386at X55885 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein -0.81889
1797_at U40343 Cyclin-dependent kinase inhibitor 2D -0.79297
38429_at U29344 Fatty acid synthase 
-0.79098
2047_sat M23410 Junction plakoglobin 
-0.78672
32181_at M60922 Flotillin 2 
-0.78316
33909_at L35013 Splicing factor 3b, subunit 4, 49kDa -0.78009
1796ssat U05681 -
-0.7781
38647_at AJ131182 Coatomer protein complex, subunit epsilon -0.76184
207_at M86752 Stress-induced-phosphoprotein 
-0.75549
419_at X65550 Antigen identified by monoclonal antibody Ki-67 -0.74995
1801_at U76638 BRCA1 associated RING domain 1 -0.74814
38269_at AL050147 Protein kinase D2 
-0.74517
38828_sat AA628946 KH-type splicing regulatory protein -0.7272
37365_at X63368 DnaJ (Hsp40) homolog, subfamily B, member 2 -0.7266
40195_at X14850 H2A histone family, member X -0.72482
40619_at M91670 Ubiquitin carrier protein 
-0.7223
33014_at AF059194 V-maf musculoaponeurotic fibrosarcoma oncogene -0.72116
39704sat L17131 High mobility group AT-hook 1 -0.71493
1486_at L37127 Polymerase (RNA) II (DNA directed) polypeptide -0.71294
40580 r at M24398 Parathymosin 
-0.71203
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Table 4.10: Genes identified by Gordon method using new training set
Gene Ratio of Student's
Probe sequence good to t test
ID No. Description poor mean p value
33273_fat X57809 Immunoglobulin lambda locus 3.3 0.0163
33274fat M18645 Immunoglobulin lambda joining 3 3.1 0.0210
41827fat AI932613 Hypothetical protein LOC51233 2.7 0.0212
33499sat AF067420 Hypothetical protein MGC27165 2.9 0.0227
33501_rat S71043 Partial mRNA for immunoglobulin 2.8 0.0232
286_at L19779 Histone 2, H2aa 2.2 0.0306
32609_at AI885852 Histone 2, H2aa 2.4 0.0478
35766_at M26326 Keratin 18 0.47 0.0068
41294_at AJ238246 Keratin 7 0.21 0.0332
additional patient variables, the resulting classification trees performed the same. The
N-fold cross validation error rate increases, however, when the 50 best Golub method
genes were used; presumably, the tree building process began to overfit the training
data. Notice also that the Gordon method performed very poorly, even worse than
simply using the 500 genes with the lowest Student's t test p value.
Furthermore, the additional patient variables - such as age, sex, tumor stage and
tumor histology - had little effect on the cross validation error rate, since the error
rate was the same for each gene set regardless of whether additional patient variables
were included. This is not surprising because, if none of these variables generated
good splits, they were simply not included in the classification tree model.
Among all of the input variable sets that gave a cross validation error rate of 9.5%,
the input variable set using the best four genes as identified by the Golub method
and no additional patient variables was selected to be applied to the test set because
it contained the fewest number of input variables.
The cross validation error rates for the neural networks applied to the classification
problem are given in Table 4.12. Notice that all of the eleven networks which achieved
a mean error rate of zero used regularization, with a coefficient of either 2.5 or .5.
All of the top 16 networks either used regularization or had a smaller size to avoid
overfitting. In fact, for all input variables sets with the exception of the Gordon
gene set, networks with regularization performed better than those with a small size,
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Table 4.11: N-fold cross
Gene set
Golub, top
Golub, top
Golub, top
Golub, top
Golub, top
Golub, top
Golub, top.
Golub, top
Lowest 500 p 
Lowest 500 p 
Gordon
Gordon
validation results for classification trees
Additional CV CV
patient error error
variables rate, % St. dev.
4
4
10
10
30
30
50
50
value
valui
No 9.5 6.6
Yes 9.5 6.6
No 9.5 6.6
Yes 9.5 6.6
No 9.5 6.6
Yes 9.5 6.6
No 28.6 10.1
Yes 28.6 10.1
e No 28.6 10.1
e Yes 28.6 10.1
No 47.6 11.2
Yes 47.6 11.2
and both of these types of network structures performed better than the networks
with large size and no regularization. It seems that the large network size with no
regularization caused the training to overfit the training data.
Both the heavier regularization with a coefficient of 2.5 and the lighter regulariza-
tion with a coefficient of .5 performed reasonably well, achieving identical results with
seven of the ten input variable sets; only in the Golub set with ten genes with addi-
tional variables and in both Gordon input variable sets did the heavier regularization
perform better than the lighter regularization.
In the case of neural networks, the additional patient variables seemed to increase
the cross validation error rates. Except for those built using the Gordon gene set, the
networks using the gene set without the additional patient variables performed as well
or better than the networks using the same gene set with the additional variables.
However, networks using regularization performed equally with or without the addi-
tional patient variables, except for those using the Gordon set and the network using
the best ten Golub genes with lighter regularization. Apparently, the regularization
was enough to counteract the confounding effects of the additional variables.
As was the case with classification trees, the networks using the Gordon gene set
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Table 4.12: N-fold cross validation results for neural networks used for classification
Additional
patient
variables
Parameters
Hidden Reg.
size coefficient
CV error rate, %
Mean St. dev. 95% CI
Golub, top 10
Golub, top 10
Golub, top 10
Golub, top 30
Golub, top 30
Golub, top 30
Golub, top 30
Golub, top 50
Golub, top 50
Golub, top 50
Golub, top 50
Golub, top 10
Golub, top 10
Golub, top 10
Golub, top 30
Golub, top 50
Golub, top 10
Golub, top 30
Golub, top 10
Golub, top 50
Golub, top 30
Golub, top 50
Golub, top 4
Golub, top 4
Golub, top 4
Golub, top 4
Golub, top 30
Golub, top 50
Gordon
Golub, top 4
Golub, top 4
Gordon
Golub, top 4
Golub, top 4
Gordon
Gordon
Gordon
Gordon
Gordon
Gordon
Gene set
No
No
Yes
No
No
Yes
Yes
No
No
Yes
Yes
No
Yes
Yes
No
No
No
No
Yes
No
Yes
Yes
No
No
No
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
No
No
Yes
No
8
8
8
8
8
8
8
8
8
8
8
2
8
2
2
2
8
8
8
8
2
2
2
8
8
8
8
8
8
8
8
8
2
8
2
8
2
8
8
8
2.5
0.5
2.5
2.5
0.5
2.5
0.5
2.5
0.5
2.5
0.5
0
0.5
0
0
0
0
0
0
0
0
0
0
2.5
0.5
0
0
0
2.5
2.5
0.5
0.5
0
0
0
0
0
2.5
0
0.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.9
1.9
2.9
3.8
3.8
4.8
4.8
7.6
7.6
8.6
8.6
9.5
9.5
9.5
9.5
9.5
9.5
11.4
14.3
14.3
16.2
19.0
21.9
21.9
22.9
23.8
23.8
25.7
26.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
4.3
4.3
2.6
2.1
4.0
4.8
5.8
6.4
6.4
4.0
2.1
0.0
0.0
0.0
0.0
8.2
6.7
2.6
0.0
0.0
2.6
4.8
2.6
9.9
4.0
0.0
0.0
4.3
4.3
[0.0, 0.0]
[0.0, 0.0]
[0.0, 0.0]
[0.0, 0.0]
[0.0, 0.0]
[0.0, 0.0]
[0.0, 0.0]
[0.0, 0.0]
[0.0, 0.0]
[0.0, 0.0]
[0.0, 0.0]
[0.0, 5.6]
[0.0,5.6]
[0.6,5.1]
[1.9,5.7]
[0.3, 7.3]
[0.6,8.9]
[0.0, 9.9]
[2.0, 13.2]
[2.0,13.2]
[5.1, 12.1]
[6.7,10.4]
[9.5,9.5]
[9.5, 9.5]
[9.5,9.5]
[9.5,9.5]
[2.3, 16.8]
[3.6,15.4]
[9.1,13.7]
[14.3,14.3]
[14.3,14.3]
[13.9, 18.5]
[14.9, 23.2]
[19.6, 24.2]
[13.2, 30.6]
[19.4, 26.3]
[23.8, 23.8]
[23.8, 23.8]
[22.0, 29.4]
[22.9, 30.4]
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performed poorly compared to those using any of the Golub gene sets. Networks
using the Gordon gene set made up the six worst networks in terms of mean cross
validation error rate, and all eight networks using the Gordon set were among the
worst twelve networks. Networks using the gene set with the best four Golub genes
performed uniformly poorly as well. With the Gordon gene set, using the additional
patient variables improved network performance, except in the large network with
no regularization. It appears that the genes included in the Gordon set generalized
so poorly that including the additional patient variables - which proved to degrade
performance in many of the other networks - actually improved the performance of
networks.
It also appears that regularization was able to counteract the effects of overfitting
and high dimensionality when the number of input variables was increased. Look-
ing at the Golub gene sets without additional patient variables, the cross validation
error for both large networks with no regularization and small networks reached a
minimum with ten genes and gradually increased as more genes were added. With
regularization, however, the error reached zero with ten genes and stayed constant as
the number of genes increased. The same was generally true for the Golub gene sets
with additional variables; for large networks with no regularization and for small net-
works, the mean cross validation error reached a minimum at ten genes and increased
as more genes were added. With regularization, however, once the minimum error
was reached, the error stayed constant as more genes were added; with the smaller
regularization this minimum was reached with 30 genes and with heavy regularization
this minimum was reached with ten genes.
If two or more networks had equal mean cross validation error rates, the one with
smallest number of inputs, the heaviest regularization, and finally the smallest size
was preferred. Therefore, although a total of eleven of combinations of input variable
sets and network structures achieved a zero mean cross validation error rate, the
network using the best ten Golub genes with no additional variables and having a
large size with a large regularization coefficient was chosen to be applied to the test
set. In order to reduce the variance of the output due to the random starting weights,
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the final model contained a total of five neural networks with identical structure; the
final output for each sample was given by the average of the outputs of the individual
networks.
The cross validation error rates for the various logistic regression models are given
in Table 4.13. Notice in logistic regression that including the additional patient
variables did not necessarily lead to degraded performance. For models using forward
and backward stepwise variable selection, this is not surprising; if a particular variable
was unimportant to the classification problem, it was not included in the final model.
Furthermore, Stata software automatically removed many variables due to colinearity,
so, even when stepwise variable selection was not used, many of the least important
variables were removed before the logistic regression models were built. Notice also
that models using the Gordon gene set performed very poorly; the best model using
the Gordon gene set had a higher cross validation error than the worst model using
any of the Golub gene sets.
It appears that models built with stepwise variable selection, either forward or
backward, did not perform consistently better or worse than models built without
stepwise selection. For the Golub set with four genes, backward stepwise selection
performed the better than any other model but forward stepwise performed no better
than simple logistic regression. For the Golub set with ten genes, forward and back-
ward stepwise selection performed worse than the simple models and, for the Gordon
gene set, forward and backward selection performed better than simple logistic re-
gression with additional variables but worse than simple logistic regression without
these variables. It would be interesting to see the results of stepwise selection on the
larger gene sets, perhaps even one containing hundreds of genes, but unfortunately
there were too few training samples for Stata software to perform stepwise analysis
on these larger input variable sets. This is limitation is specific to Stata software,
since many other programs such as SAS are able to perform stepwise selection with
large number of input variables.
Although two models had a cross validation error rate of zero, the Golub set with
four genes and no additional variables was applied to the test set because it contained
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Table 4.13: N-fold cross validation results for logistic regression models
Gene set
Golub, top 4
Golub, top 4
Golub, top 50
Golub, top 4
Golub, top 4
Golub, top 4
Golub, top 10
Golub, top 10
Golub, top 30
Golub, top 50
Golub, top 4
Golub, top 10
Golub, top 10
Golub, top 10
Golub, top 10
Golub, top 30
Gordon
Gordon
Gordon
Gordon
Gordon
Gordon
Additional
patient
variables
No
Yes
Yes
No
No
Yes
No
Yes
Yes
No
Yes
No
Yes
Yes
No
No
No
Yes
Yes
No
No
Yes
fewer input variables than the other model with zero cross validation error.
The estimated cross validation error rates for support vector machine models are
given in Table 4.14. A curious result of the support vector machines was that the
estimates of cross validation error rates were the same for each input variable set
regardless of the kernel function. This was most likely caused by the fact that the
SVMlight software only used a select few samples to produce its estimates of the error
rate; while this may be a reasonable approach for large training sets, it is not accurate
with a small training set like the one used here. Unfortunately, this property could
not be changed within the software. The software also produced another estimate,
called the XiAlpha estimate, of the model error; this estimate was also constant for
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Stepwise
variable
selection
Backward
Backward
None
None
Forward
Forward
None
None
None
None
None
Forward
Backward
Forward
Backward
None
None
Backward
Forward
Backward
Forward
None
CV
error
rate, %
0.0
0.0
9.5
14.3
14.3
14.3
14.3
14.3
14.3
14.3
19.0
19.0
19.0
19.0
23.8
23.8
28.6
33.3
33.3
38.1
38.1
38.1
-
-
each input variable set regardless of kernel function. The fact that the error was
constant for each input variable set may have been caused by the regularization
coefficient, which was set automatically by the software based on the kernel function.
This regularization may have effectively regularized each kernel to the point that each
gave comparable results. The actual output was different for each kernel, however.
Varying this coefficient did not change the results in any noticeable way.
Because the cross validation and XiAlpha estimates for the error were constant
for each input variable set, the results from support vector machines were, for the
most part, uninteresting. Using a Golub set with ten or more genes and any kernel
function gave a cross validation error estimate of zero and, except for the Golub set
with ten genes and additional patient variables, these all gave the same XiAlpha error
estimates. Notice again that the Gordon gene set performed worse than all other gene
sets with or without additional patient variables.
All other things being equal, the model using the smallest input variable set or
simplest kernel function was preferred. Thus, the model using a linear kernel function
and the Golub set with ten genes and no additional patient variables was chosen over
the other models with cross validation error estimates of zero to be applied to the
test set.
Regression results
Results for the regression analysis using neural networks are given in Table 4.15. The
error is reported as the average sum of squares error for each of the N-fold cross
validation samples. Notice that five of the top six models used a small network size
to avoid overfitting. In fact, for five of the ten input variable sets, the network with
a small size performed significantly better than any of the other network structures.
Networks with the larger regularization coefficient performed better than networks
with the smaller regularization coefficient in all but one case and this difference was
significant in all but one of the case; in the one case where the smaller coefficient
performed better - the Golub set with 50 genes and no additional variables - the
difference was negligible.
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Table 4.14: Cross validation error estimates for support vector machine models
Additional
patient
variables
Kernel
function
CV
error
estimate, %
XiAlpha
error
estimate, %
Golub, top 10
Golub, top 10
Golub, top 10
Golub, top 10
Golub, top 10
Golub, top 10
Golub, top 10
Golub, top 10
Golub, top 30
Golub, top 30
Golub, top 30
Golub, top 30
Bolub, top 50
Bolub, top 50
Bolub, top 50
Bolub, top 50
Bolub, top 50
Bolub, top 50
Bolub, top 50
Bolub, top 50
Golub, top 30
Golub, top 30
Golub, top 30
Golub, top 30
Golub, top 4
Golub, top 4
Golub, top 4
Golub, top 4
Golub, top 4
Golub, top 4
Golub, top 4
Golub, top 4
Gordon
Gordon
Gordon
Gordon
Gordon
Gordon
Gordon
Gordon
No
No
No
No
Yes
Yes
Yes
Yes
No
No
No
No
No
No
No
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
No
No
No
Yes
Yes
Yes
Yes
No
No
No
No
Linear
Polynomial, degree 2
Polynomial, degree 4
Radial basis
Linear
Polynomial, degree 2
Polynomial, degree 4
Radial basis
Linear
Polynomial, degree 2
Polynomial, degree 4
Radial basis
Linear
Polynomial, degree 2
Polynomial, degree 4
Radial basis
Linear
Polynomial, degree 2
Polynomial, degree 4
Radial basis
Linear
Polynomial, degree 2
Polynomial, degree 4
Radial basis
Linear
Polynomial, degree 2
Polynomial, degree 4
Radial basis
Linear
Polynomial, degree 2
Polynomial, degree 4
Radial basis
Linear
Polynomial, degree 2
Polynomial, degree 4
Radial basis
Linear
Polynomial, degree 2
Polynomial, degree 4
Radial basis
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Gene set
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
9.5
9.5
9.5
9.5
14.3
14.3
14.3
14.3
19.1
19.1
19.1
19.1
23.8
23.8
23.8
23.8
28.6
28.6
28.6
28.6
38.1
38.1
38.1
38.1
28.6
28.6
28.6
28.6
28.6
28.6
28.6
28.6
28.6
28.6
28.6
28.6
28.6
28.6
28.6
28.6
42.9
42.9
42.9
42.9
28.6
28.6
28.6
28.6
42.9
42.9
42.9
42.9
52.4
52.4
52.4
52.4
Table 4.15: N-fold cross validation results for neural networks used for regression
Additional
patient
variables
Parameters
Hidden
size
Reg.
coefficient
CV average
sum of squares error
Mean St. dev. 95% CI
Golub, top 50
Golub, top 50
Golub, top 10
Golub, top 30
Golub, top 30
Golub, top 30
Golub, top 50
Golub, top 50
Golub, top 50
Golub, top 30
Golub, top 30
Golub, top 50
Golub, top 10
Golub, top 10
Golub, top 30
Gordon
Golub, top 10
Golub, top 10
Golub, top 30
Golub, top 50
Golub, top 10
Gordon
Golub, top 50
Golub, top 4
Gordon
Golub, top 30
Golub, top 10
Gordon
Golub, top 10
Golub, top 4
Golub, top 4
Gordon
Gordon
Golub, top 4
Golub, top 4
Gordon
Golub, top 4
Golub, top 4
Golub, top 4
Gordon
Yes
No
No
No
Yes
No
No
No
Yes
Yes
No
Yes
No
Yes
No
Yes
No
No
Yes
No
Yes
Yes
Yes
Yes
No
Yes
Yes
No
Yes
Yes
No
No
Yes
Yes
No
No
No
No
Yes
Yes
2
2
2
8
2
2
8
8
8
8
8
8
8
2
8
8
8
8
8
8
8
2
8
8
8
8
8
8
8
2
8
2
8
8
8
8
2
8
8
8
0
0
0
2.5
0
0
0.5
2.5
2.5
2.5
0
0.5
2.5
0
0.5
2.5
0
0.5
0.5
0
2.5
0
0
2.5
2.5
0
0.5
0.5
0
0
2.5
0
0.5
0.5
0.5
0
0
0
0
56.5
58.3
62.6
65.9
66.2
67.5
70.0
70.9
71.8
72.8
74.0
76.2
80.5
82.0
84.0
86.1
87.8
88.0
100.6
101.7
106.0
106.4
107.9
108.9
114.5
115.0
119.4
127.6
130.3
130.4
132.0
139.2
147.3
155.0
195.7
201.6
202.9
224.7
262.9
5.2
4.0
9.2
6.3
4.2
11.1
7.1
9.7
3.9
3.7
17.3
14.0
10.9
22.1
15.5
10.0
19.7
7.8
29.3
30.6
6.7
18.0
9.8
5.5
14.5
19.4
6.7
15.3
26.5
30.7
4.6
39.7
31.0
29.8
15.0
54.4
48.1
39.1
79.1
[52.0,61.1]
[54.8,61.8]
[54.6, 70.7]
[60.4, 71.4]
[62.5,69.9]
[57.8,77.2]
[63.8, 76.1]
[62.3, 79.4]
[68.4, 75.2]
[69.6, 76.1]
[58.9, 89.2]
[63.9,88.5]
[71.0,90.0]
[62.6,101.4]
[70.4,97.6]
[77.3,94.9]
[70.5,105.1]
[81.2,94.8]
[75.0,126.3]
[74.9,128.6]
[100.2,111.9]
[90.6,122.2]
[99.3,116.5]
[104.1,113.6]
[101.8,127.2]
[98.0,132.0]
[113.5,125.3]
[114.2,141.0]
[107.0,153.5]
[103.5,157.4]
[128.0,136.0]
[104.4,174.0]
[120.1,174.5]
[128.9,181.1]
[182.5,208.9]
[153.9,249.2]
[160.7,245.1]
[190.4,259.0]
[193.5,332.3]
0 307.0 122.4 [199.7, 414.3]
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Gene set
__ 
A networks with a large size and no regularization only performed better than
another type of network structure in one case, the Golub set with ten genes and no
additional variables. Thus, it appears that this network structure was very sensitive
to overfitting, as was the case in the networks built for the classification problem.
Again, the Gordon gene set generated very poorly performing models; the worst model
used the Gordon gene set and none of the Gordon models were among the best 15
models. Additional variables did not seem to be very helpful in the regression problem
either. In the 20 comparable networks between networks using input variable set with
additional variables and those not using additional input variables, the network using
the additional variables performed better in only six of these cases, and this difference
was significant in only two cases. On the other hand, in twelve of these cases, the
network without the additional variables performed significantly better.
As can be seen from Table 4.15, the best network in terms of mean cross validation
error performs significantly better than all but the second best network. Thus, the
network using the Golub set with 50 genes and additional variables and having a small
size was applied to the test set. The final model contained a total of five networks
with identical structure; the final output was given by the average of the individual
networks.
Classification results using the test set
A total of four models were applied to the test set; the results of these model are
given in Table 4.16. The sensitivity, specificity, and accuracy were calculated using a
total of seven samples; the logrank and Cox proportional hazard regression tests were
calculated using these seven samples plus an additional three right-censored samples.
The final classification tree model uses only two genes, 40489_at and 33428_at, and,
in the final logistic regression model, backward stepwise variable selection eliminates
all but a single variable, the gene with probe identification 35151at.
The neural network and support vector machine models performed the best in
terms of both combined sensitivity and specificity and ROC area. The logistic re-
gression model results suggest that it was a completely uninformative test since all
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Table 4.16: Results of the best of each type of model when applied to the test set
Training set performance
Add. ROC Logrank Cox
Model type Gene set var. Sens. Spec. Acc. area a p value p value
Neural network, Golub, top 10 No 1.00 0.33 0.71 0.67 0.219 0.265
8 hidden neurons, reg coeff of 2.5
Logistic regression, Golub, top 4 No 1.00 0.00 0.57 0.50 0.432 _b
Backward stepwise selection
SVM, Golub, top 10 No 1.00 0.33 0.71 0.67 0.515 0.529
Linear kernel function
Classification tree Golub, top 4 No 0.50 0.33 0.43 0.42 0.235 0.296
aROC area is calculated using the single point (1 - specificity, sensitivity) so that calculations
will not favor models that support a range of cutoff values over models with only one possible cutoff.
bTest did not converge.
test samples were classified as good outcome, thus giving the test an ROC area of
.5. The classification tree model performed even worse than the logistic regression
model, achieving an ROC area of .42; thus, the ROC curve actually falls below the
45° line.
The logrank and Cox proportional hazard regression p values used more samples
than the sensitivity and specificity calculations, and so may be more reliable measures
of model performance. Although the support vector machine model performed well
in terms of ROC area, it performed the worst in terms of logrank and Cox hazard
regression p values. The logistic regression model also performed poorly in terms of
logrank p value - note that the Cox proportional hazard regression p value is not
given for the logistic regression model because the calculations failed to converge in
Stata software. The classification tree model, despite performing poorly in terms of
ROC area, had lower p values than both the logistic regression and support vector
machine models. The neural network model, however, performed the best in terms of
both ROC area and logrank and Cox hazard regression p values. The Kaplan-Meier
survival curves used to perform the logrank tests are shown in Figures 4-2 through 4-5.
Note that none of these four models produced a split with a p value of less than .05;
thus, none produced a statistically significant split in terms of patient survival between
the two predicted classes. However, since so few samples were used to generate these
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Figure 4-2: Kaplan-Meier
dictions
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Figure 4-3: Kaplan-Meier
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survival curves based on the logistic regression model pre-
survival curves based on the classification tree model pre-
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Figure 4-4: Kaplan-Meier survival curves based on the neural network model predic-
tions
Figure 4-5: Kaplan-Meier
predictions
survival curves based on the support vector machine model
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Table 4.17: Regression results of the best neural network applied to the test set
Additional
patient
Model type Gene set variables
Neural network, Golub, top 50 Yes
2 hidden neurons, no reg
Average Average
training set CV sum
sum of of squares
squares error error
35.3 56.5
Average Average
test set sum test set
of squares absolute
error error
16.0 4.6
values, it is not surprising that these p values were not small, even if the models were
very good. In general, since the test set was extremely small, these results have a
very high variance. These results are not meant to provide conclusive assessments of
the four final models; rather they are given simply to provide some basic evaluation
and comparison between the four models.
Neural network regression results using the test set
The results of the final neural network regression model when applied to the test set
are given in Table 4.17. The average test error is given both in terms of average sum
of squared error, which is the typical error measure, and in terms of average absolute
error. Notice that the average sum of squared error on the test set was much lower
than both the mean cross validation sum of squares error and the training set sum
or squares error; the training set error refers to the error calculated on the training
samples using the predictions from the final model. Most of the training set and
cross validation error comes from a single sample - sample number 72 - which has
a survival much higher than the next training sample. In N-fold cross validation,
the network trained using the other samples did not generalize well to this outlying
sample; in the final model, the simple structure of each individual network, which
helped to avoid overfitting, did not allow this sample to be modeled well.
The neural network model appears to have predicted the survival of the test
samples reasonably well; on average, the predictions were off from the actual survival
by only 4.6 months. However, as was the case in the classification models, this test
set was so small - containing only six samples - that the variance of the test set error
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was likely to be extremely high. Thus, these results cannot be trusted as a reliable
measure of the ability of the model to generalize to new samples; rather, they are
meant only as a simple evaluation of the model's performance on a small number of
previously unseen samples.
4.3 Discussion of results
Many of the individual results were discussed as they were presented in Sections 4.1
and 4.2. In general, it appears that the Gordon method did not do well in general
to identify differentially expressed genes that build robust predictive models. While
the method appears to have performed reasonably well when only the best and worst
samples in terms of survival were included in the training set, it only identified a
very limited number of genes in the randomly selected training set used throughout
much of the analysis. Furthermore, in almost all cases, models built using the genes
identified by the Gordon method were clearly inferior in terms of cross validation
error to those built using the any number of genes identified by the Golub method.
The Golub method had the added benefit of being able to identify any number of
genes without needing to change constraints, since more genes can be easily selection
from the list ranked by signal-to-noise ratio.
As for the various types of machine learning used to build predictive models,
neural networks performed the best in general on a number of different types of input
variable sets. Both a small number of hidden neurons and some form of regularization
were effectively used to avoid overfitting the training samples, leading to models that
generalized fairly well regardless of the dimensionality of the input data. The best
neural network model achieved a cross validation error rate of zero and correctly
classified five of the seven test samples into good and poor outcome groups. While
they performed well, one of the biggest downsides to neural network models, however,
is the fact that they are very difficult to interpret.
Several support vector machines also had a cross validation estimate of zero, al-
though this estimate did not actually use all of the training samples. The best SVM
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also correctly predicted five of the seven test samples correctly. A curious result of
the support vectors machines was that all of the kernel functions produced identical
results on every one of the input variable sets.
Classification trees did not perform overly well, either in cross validation or on
the test set. The best classification tree model had a reasonable cross validation
error rate of 9.5% on the training set but had an ROC area of less than .5 on the
test set. The logistic regression also did not perform well, although the stepwise
variable selection which can be performed by many statistical software packages was
an attractive option. A logistic regression model with backward stepwise selection
achieved a zero cross validation error rate but did not generalize well to the - albeit
small - test set.
The additional patient variables - such as age, sex, tumor type and tumor histol-
ogy - did not appear to be helpful in predicting survival for mesothelioma patients.
In almost all cases, including these variables led to equivalent or worse performance
compared to the corresponding model without these variables. This was expected,
however, since the one among these variables that is most often used as a predictor
of patient outcome, epithelial tumor subtype, gave a logrank p value of .399 for all of
the data set samples, well above the statistically significant level.
The method of building the ratio-based predictors seemed somewhat sensitive to
the software used to generate the gene expression matrix, since the most accurate
predictors with both the older and newer data sets did share some, but not all, of
the same genes. Furthermore, none of the predictors generated using the newer data
set classified the training set with 100% accuracy and the variable selection method
identified far fewer genes in the newer data set than in the original data set.
Without an independent test set, it is difficult to compare the ratio-based pre-
dictor created by Gordon et al to any of the other models built with the various
machine learning techniques. The method of building these ratio-based predictors
did have a high N-fold cross validation error rate of 35%, much higher than the best
model built with any of the four machine learning techniques. While this result may
be biased because of the different training sets, the method of building ratio-based
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predictors may not be the best choice because it does not take advantage of all of the
training data - only the samples in the 75 th percentile and above and samples in the
25 th percentile and below are used - and because it imposes some seemingly ad hoc
restrictions during gene selection. However, the ratio-based predictors of Gordon et
al are interpretable and easy to calculate and have been shown to have good perfor-
mance on a relatively large independent test set. Furthermore, among other benefits,
the use of ratios allows gene expression levels collected using various methods to be
used in the same analysis [15].
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Chapter 5
Future Work
New ratio-based models were built by applying the method of the Gordon et al study
to the newer and presumably more accurate gene expression matrix; furthermore,
using various machine learning methods, four models were built using a randomly
generated training set and compared using N-fold cross validation and a small test
set. Ultimately, these models will need to be compared to one another - and to the
ratio-based predictor originally created by Gordon et al- by using a large independent
test. A large independent test set would reduce the variance in the results and allow
for meaningful and reliable comparisons between the various models. The best model
could then be selected to be used in practice to predict survival for patients with
mesothelioma, thus helping to guide treatment of the disease.
Therefore, the next step in this analysis is to collect and analyze tumor samples
to be used as a test set. Since 29 samples have already been collected at BWH which
were not included in the data set [15], these samples only need to be analyzed using
microarrays in order to generate a test set; PCR could even be used since a very
limited number of genes - ten or less genes in most cases and only four genes in
some - were used in each of models. Collecting and analyzing these samples using
microarrays or PCR is a job for biologists rather computer scientists, however.
Without an independent set of samples to use to test these models, none of the
constructed models can safely be used in practice to guide patient treatment. These
models were built based on at most 21 samples and, apart from cross validation,
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tested using at most seven uncensored samples; in the absence of a larger test set,
the results of these models are unreliable at best. Thus, the collection and analysis
of a large test set of new mesothelioma tumor samples are crucial to the success of
using variable selection and machine learning methods to positively affect the quality
of life of patients with malignant pleural mesothelioma.
Application of the methods in another domain may give some indication of whether
the ratio-based classifier has a more general use than the one described by Gordon et
al. As large data sets become available, extension of the experiments described here
to other biomedical domains would help to answer this type of question.
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Chapter 6
Contributions
This thesis investigated a number of different methods for building models to predict
postoperative survival for patients who underwent extrapleural pneumonectomy as
a result of malignant pleural mesothelioma. A patient was classified as having a
poor outcome if his or her survival was less than the median survival length of 11
months and as having a good outcome if his or her survival was greater than or
equal to 11 months. The method of building ratio-based predictors originally used
by Gordon et al was recreated using both the original data set and a newer data
set which contained the same samples but was generated with a newer version of
Affymetrix software. In addition to recreating these results, several variable selection
methods and machine learning techniques were explored using the newer data set and
a randomly chosen training set. These machine learning techniques included decision
trees, logistic regression, artificial neural networks, and support vector machines.
The results showed that neural networks generalized the best of the four main
types of models, achieving an N-fold cross validation error rate of zero and a logrank
p value on the test set of .219. The best support vector machine model also performed
very well. Logistic regression and decision trees generalized poorly, for the most part.
Furthermore, the Gordon method of variable selection was shown to perform very
poorly compared to the Golub method on the random training set, since models
built using the Gordon method genes performed among the worst in terms of cross
validation error for all model types.
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Lastly, many of the neural network, support vector machine, logistic regression,
and decision tree models achieved an N-fold cross validation error of, or close to, zero.
However, the ratio-based predictors had a much higher cross validation error of 35%.
While the ratio-based method used a different training set than the other models,
it would seem that the other models generalize better than the ratio-based ones; an
independent test set would be needed to confirm this speculation.
These results may help guide future researchers to select methods appropriate for
variable selection and machine learning in microarray data analysis. Furthermore,
since a number of tumors have already been collected to be used as a test set, the
results presented in this paper may used to guide researchers as to which new genes
to analyze in these samples using PCR. This data could then be used to compare the
performance of the new models with that of the ratio-based model originally built by
Gordon et al. The best performing model could then be used reliably in practice to
predict patient survival following EPP, thus helping to guide treatment and improve
overall survival for patients with MPM. Such a predictor could eventually lead to new
types of treatment for a disease which is currently incurable.
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